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ABSTRACT 
 Gene regulation is controlled by DNA-bound complexes of transcription factors 
(TFs) and indirectly recruited transcriptional cofactors (COFs). Understanding how and 
where these TF-COF complexes bind in the genome is fundamental to our understanding 
of the role of cis-regulatory elements (CREs) in gene regulation and our mechanistic 
interpretation of non-coding variants (NCVs) known to impact gene expression levels. In 
this thesis, I present three related array-based techniques for the high-throughput profiling 
of DNA-bound TFs and TF-COF complexes directly from cell nuclear extracts. 
 First, I describe the nuclear extract protein-binding microarray (nextPBM) 
approach to profile TF-DNA binding using nuclear extracts to account for cell-specific 
post-translational modifications and cofactors. By analyzing cooperative binding of 
PU.1/SPI1 and IRF8 in monocytes, I demonstrate how nextPBM can be used to delineate 
DNA-sequence determinants of cell-specific cooperative TF complexes. 
 Second, I present the CASCADE (Comprehensive ASsessment of Complex 
Assembly at DNA Elements) approach to simultaneously discover DNA-bound TF-COF 
 
 viii 
complexes and quantify the impact of NCVs on their binding. To demonstrate 
applicability of CASCADE to screen NCVs, I profile differential TF-COF binding to 
~1,700 single-nucleotide polymorphisms in human macrophages and discover a 
prevalence of perturbed ETS-related TF-COF complexes at these quantitative trait loci. 
 Third, I present the human TF array (hTF array) as a general platform for 
surveying COF recruitment to a panel of 346 non-redundant consensus TF binding sites 
(TFBSs). Using the hTF array, one can examine the activity of a diverse panel of TFs by 
profiling TF-COF complexes in a cell state-specific manner. In addition to the hTF 
microarray design, I have developed analysis and visualization software that allows users 
to explore COF recruitment profiling results interactively. 
 Collectively, nextPBM, CASCADE, and the hTF array represent a suite of new 
approaches to investigate TF-COF complex binding and their application will refine our 
understanding of CREs by linking NCVs with the biophysical complexes that mediate 
gene regulatory functions.  
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CHAPTER ONE: Introduction 
1.1 The role of transcription factors in enhancer selection and gene regulation 
 Transcription factors (TFs) are a class of DNA-binding proteins that are expressed 
and activated in response to developmental or environmental cues to regulate the 
expression of their target genes. TFs in turn influence gene regulatory activities through 
interactions with non-DNA-binding proteins and protein complexes referred to 
collectively as transcriptional cofactors (COFs). These COFs that are indirectly recruited 
to DNA via TFs are considered effectors of gene regulation since many have enzymatic 
activity required to facilitate gene expression, such as modification of histones and 
remodeling of chromatin (Fig. 1.1) (Reiter et al., 2017; Zabidi and Stark, 2016; Shlyueva 
et al., 2014). TFs bind throughout the genome in a DNA sequence-specific manner. The 
DNA sequence preferences of TF binding are typically modeled using position-weight 
matrices (PWMs) that represent binding using the probability of observing a given 
nucleotide at a given position within the binding sites of the TF (Fig. 1.1) (Stormo and 
Fields, 1998; Siggers and Gordân, 2014). These DNA-binding preferences can also be 
visualized using sequence logos (Fig. 1.1) (Schneider and Stephens, 1990). As the 
genome across all cell types within an individual is largely identical and the nucleotide 
composition of a DNA sequence determines which TFs can bind a given segment, 
deciphering the logic of gene regulation in diverse cell types and stimulus responses 
fundamentally depends on our ability to determine which TFs are expressed and active in 
a given context, what their binding preferences are, and which COFs are subsequently 





Figure 1.1: Overview of transcriptional regulation by TFs and COFs 
COFs are recruited to TF sites on DNA (solid arrows) and have enzymatic activity such as 
histone modification and interaction with RNA polymerase II (RNAPII) and the general 
transcriptional machinery to influence how genes are expressed (mRNA). Different TFs display 
distinct DNA-binding preferences that can be modeled using PWMs and visualized using 
sequence logos. 
 
 TFs can be broadly classified by their functional properties and the role the play 
in gene regulation (Vaquerizas et al., 2009; Lambert et al., 2018; Smale, 2012). Many 
TFs for example are expressed in response to developmental cues and influence the 
regulatory potential of a given cell type or lineage (Heinz et al., 2013; Lin et al., 2010; 
Heinz et al., 2010; Johnson et al., 2018). For example, in monocytes and macrophages, 
important sentinel white blood cells of the immune system, the enhancer landscape is 
thought to be established by a small panel of lineage-determining transcription factors 
(LDTFs) including SPI1/PU.1 (Heinz et al., 2010). Once expressed, PU.1 uses its 
“pioneer” activity to bind to closed chromatin in a process thought to remodel local 
chromatin by displacing histones and exposing proximal regulatory binding sites to be 
targeted by TFs that do not possess this same pioneer capability (Heinz et al., 2010; 
Heinz et al., 2013; Heinz et al., 2015). This developmental process effectively establishes 




lineage- and cell type-specific enhancers that confer and maintain the identity of a given 
cell type. An additional class of TFs includes those that are activated or expressed in 
response to environmental stimuliA well-characterized example in macrophages is the 
NF-κB complex that is activated in response to diverse stimuli including the detection of 
bacterial lipopolysaccharide (LPS) found at the surface of harmful pathogens (Xie et al., 
1994; Hwang et al., 1997, Heinz et al., 2010; Heinz et al., 2013; Heinz et al., 2015). NF-
κB binding to the regulatory elements established by pioneer factors such as PU.1 results 
in the robust stimulus-dependent activation of programs of proinflammatory genes that 
function in concert to respond to the threat of a potential pathogen (Heinz et al., 2010; 
Natoli et al., 2011; Heinz et al., 2013; Ostuni et al., 2013; Heinz et al., 2015). 
 As TFs like PU.1 and NF-κB recruit transcriptional cofactors with enzymatic 
activities, regulatory elements established by these and other TFs can be located genome-
wide through profiling the chemical modifications that are introduced by these recruited 
COFs. For example, many of the myeloid regulatory elements established by PU.1 and 
subsequently bound by signal-dependent TFs such as NF-κB in macrophages are also 
marked with histone modifications characteristic of primed and active enhancers such as 
histone 3 lysine 4 mono-methylation (H3K4me1) and histone 3 lysine 27 acetylation 
(H3K27ac) as well as by the presence of the general histone acetyltransferase (HAT) 
p300 (Ghisletti et al., 2010; Natoli et al., 2011; Ostuni et al., 2013; Heinz et al., 2013). 
Beyond these two enhancer marks, there exists a number of additional histone 
modifications established by recruited enzymes whose combinations are thought to 




primed enhancers, poised enhancers, and active enhancers) (Heintzman et al., 2007; Ernst 
et al., 2011; Ernst and Kellis, 2012). Understanding the grammar of regulatory element 
selection and maintenance genome-wide is therefore a complex problem of understanding 
where and why a TF can bind to a given DNA site and which enzymatic COFs can be 
consequently recruited to these TF sites. 
 Due to the important role of TFs in establishing and maintaining regulatory 
elements, there exists massive cooperative efforts to map the genome-wide binding sites 
of different TFs and locations of non-coding regulatory elements in diverse cell types and 
contexts (for example ENCODE and modENCODE) (Feingold et al., 2004; Birney et al., 
2007; Gerstein et al., 2010). In addition, as TFs are sequence-specific DNA binding 
proteins, there also exists community resources and databases such as JASPAR (Sandelin 
et al., 2004; Fornes et al., 2020) , CIS-BP (Weirauch et al., 2014), Transfac (Wingender 
et al., 2000), UNIPROBE (Newburger and Bulyk, 2009), HOCOMOCO (Kulakovskiy et 
al., 2013; Kulakovskiy et al., 2018), and MotifDb (Shannon and Richards, 2018) 
dedicated to the collection of PWM models for different TFs that can be used to predict 
the binding sites of these factors. These community efforts to dissect the complex 
grammar of gene regulation at the level of non-coding DNA elements underscore the 
importance of TFs and exist due to the availability of diverse and effective methods to 
map the genome-wide binding sites of TFs and characterize the nucleotide determinants 




1.2 Current methods to profile TF-DNA binding preferences 
 Several methods currently exist to profile the binding locations of TFs such as 
ChIP-seq (reviewed in Furey, 2012) and elucidate the nucleotide determinants of their 
binding (reviewed in Inukai et al., 2017). Each of these methods have their own 
advantages and drawbacks. The protein-binding microarray (PBM) for example is an in 
vitro method for measuring TF-DNA binding preferences (Mukherjee et al., 2004; Berger 
and Bulyk, 2006). In brief, a protein of interest is either expressed/tagged and incubated 
on a double-stranded DNA microarray consisting of up to hundreds of thousands of 
unique sequences. The TF of interest is subsequently probed with a primary antibody 
(specific to that TF) and binding of the primary antibody is detected in turn using a 
fluorophore-conjugated secondary antibody. Intensity of the fluorescence is measured 
and has been shown to be proportional to the TF’s affinity for a given DNA probe. A 
distinct advantage of the PBM over other technologies, such as the widely used genomic 
chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) 
assay (discussed below), is the customizability of the DNA probes on the array. As any 
set of customized DNA probes can be included on the array (within a probe number 
limit), groups have developed creative designs to elucidate the DNA-binding preferences 
of TFs using the PBM platform (Berger and Bulyk, 2009; Newburger and Bulyk, 2009). 
The Universal PBM design for example uses a k-mer-based approach to directly compare 
TF binding intensities at a “seed” reference DNA probe and all of its single nucleotide 
variants providing a method to determine the single nucleotide determinants of TF 




cellular context (an in vitro setting) where the potential influence of all cellular post-
translational modifications (PTMs) and cooperative/collaborate protein cofactors on the 
binding of a TF of interest cannot be taken into account. Nonetheless, the PBM has 
facilitated efforts to characterize the DNA-binding models of TFs. The aforementioned 
Universal PBM design for example has been used to characterize the binding models of 
hundreds of TFs which are compiled in the widely used UNIPROBE resource 
(Newburger and Bulyk, 2009) which is in turn included in meta-databases such as 
MotifDb (Shannon and Richards, 2018).  
 Similar in vitro techniques to the PBM exist, such as high-throughput systematic 
evolution of ligands by exponential enrichment (HT-SELEX) and the related SELEX-
seq, which in place of a microarray use a library of DNA probes (Jolma et al., 2010; 
Riley et al., 2014). These probes are incubated with TFs of interest and undergo multiple 
rounds of selection in order to identify the DNA probes preferentially bound by the 
protein of interest. These probes are then sequenced and analyzed to determine the 
binding preferences of the given TF. As with the PBM, the probe selection does not need 
to be limited to genomic sequences, allowing researchers to screen the impact of different 
DNA variants on the binding of a TF and develop customized library designs to fit their 
research questions. However, HT-SELEX and SELEX-seq suffer from many of the same 
caveats as the PBM since they are both in vitro techniques. The impact of cell-specific 
phenomena such as PTMs and cofactors are therefore not taken into account in these 




 In addition to in vitro techniques used to study TF-DNA binding, such as the 
PBM and HT-SELEX/SELEX-seq, there exists in vivo techniques such as the widely 
used ChIP-seq (Birney et al., 2007; Johnson et al., 2007). Briefly, TFs in cells are cross-
linked to DNA using a fixing agent, the DNA is fragmented, and DNA segments bound 
by a TF of interest are precipitated using an antibody (similar to how the TF of interest is 
detected in the PBM assay). The precipitated DNA is then purified, amplified, and 
sequenced. Computational methods to map these sequencing reads back to a reference 
genome and determine areas of locally enriched mapped reads (often termed ‘peaks’) 
allow researchers to determine likely binding sites for their TF of interest (Zhang et al., 
2008; Guo et al., 2012; Xing et al., 2012). Models for the DNA-binding preferences of 
TFs can be computed using de novo motif inference techniques based predominantly on 
the occurrence and frequency of k-mers within the peaks uncovered (Heinz et al., 2010; 
Bailey et al., 2009; Machanick and Bailey, 2011; Ma et al., 2014). Relative to in vitro 
techniques, ChIP-seq offer the distinct advantage of profiling in the cellular context 
where the influence of cell-specific phenomena such as PTMs and 
cooperative/collaborative cofactors. In addition, determining the genomic binding sites of 
a TF can inform additional analyses and integration with other modalities such as RNA-
seq to infer the target genes of a TF and map gene regulatory networks in response to 
stimuli (reviewed in Adigun et al., 2015). However, in regards to determining the TF 
binding specificities, the technique possesses certain limitations. For example, many of 
the ‘peaks’ found in a ChIP-seq experiment will not contain an identifiable binding site as 




sites where the individual contributions of these sites toward TF binding and cis-
regulatory element (CRE) function cannot be distinguished without additional 
experimentation (Inukai et al., 2017; MacQuarrie et al., 2011). Furthermore, the binding 
data is limited to the sequences naturally occurring within the genetic sequence within the 
organism being profiled. Therefore, elucidating the impact of a specific hypothetical 
DNA nucleotide variant of interest is not possible if the variant does not already occur in 
the cell being interrogated whereas with in vitro assays, binding to DNA variants can be 
directly interrogated. Due to its many advantages and applications, ChIP-seq has been 
widely employed by the community and coordinated efforts to map the genome-wide 
binding of TFs in diverse cell types and contexts, such as the ENCODE (Feingold et al., 
2004) and modENCODE consortia (Gerstein et al., 2010), have contributed 
immeasurably to our understanding of TF binding and gene regulatory function. 
 Thus far, the methods of profiling TF binding discussed have been limited to one 
TF per experiment. Recently, a high-throughput (HT) electrophoretic mobility shift assay 
(EMSA) and mass spectrometry-based technique called Active TF Identification (ATI) 
was developed to profile the binding preferences of all TFs in the cell (Wei et al., 2018). 
This is achieved by incubating DNA oligomers with nuclear extracts, isolating all 
protein-DNA complexes by EMSA, and then analyzing the captured DNA sequences 
using HT sequencing and the captured proteins by mass spectrometry. Computational 
approaches are then used to infer the various DNA binding models (i.e. PWMs) and to 
match them with the TFs identified by mass spectrometry. The ATI method offers an 




profiled at a time. This increased profiling throughput at the TF-level however comes 
with the cost of not being able to directly identify the genomic binding sites of the TFs 
with certainty. Together, these methods are effective but demonstrate a historical focus at 
characterizing TF binding preferences and binding sites over the functional potential of 
different sites. Comparatively less effort has been placed in developing techniques for 
determining mapping the nucleotide determinants of functional higher-order regulatory 
complexes and the recruitment sites of transcriptional COFs, the enzymatic effectors of 
gene regulatory processes like histone modification and chromatin remodeling. 
1.3 Importance of studying DNA-binding preferences of TFs and higher-order 
complexes 
 An important reason to study the DNA-binding preferences of TFs and higher 
order gene regulatory complexes is their potential role in aberrant cell states and disease. 
A key finding from over a decade’s worth of genome-wide association studies (GWAS) 
is that the vast majority of  DNA sequence polymorphisms linked to disease occur in 
non-coding sections of the genome (Gallagher and Chen-Plotkin, 2018). These non-
coding polymorphisms do not affect the sequence of an expressed protein but can instead 
perturb how the expression of a protein (or multiple proteins) is/are regulated resulting in 
consequences at the phenotype level. Of the disease-associated polymorphisms that occur 
within the non-coding genome, a substantial portion have been demonstrated to occur 
within cell type-specific gene regulatory elements (Maurano et al., 2012; Farh et al., 
2015). Understanding the role of genetics in disease therefore depends on our ability 




such as promoters and enhancers and with particular focus on cell type-specific 
regulatory elements. 
 A primary mechanism by which DNA variants alter gene expression is by altering 
the DNA binding of TFs. Previous studies conducted to estimate the prevalence of 
disease-associated variants in suspected TF binding sites have found that only 10-20% 
likely perturb the binding of a TF with a previously characterized binding model (Farh et 
al., 2015). Our inability to link variants with altered TF binding has contributed to a 
widening gap between the ease with which we can statistically associate a non-coding 
DNA variant with a phenotypic outcome and our ability to functionally determine the 
molecular mechanisms that explain these associations (Gallagher and Chen-Plotkin, 
2018). For example, there exists HT techniques to link DNA variants uncovered in 
GWAS with gene expression outcomes. RNA-seq can be combined with genotyping for 
example in a cell-specific manner to uncover expression quantitative trait loci (eQTLs) to 
statistically associate DNA variants with some allelic change in gene expression (Sun and 
Hu, 2013; Majewski and Pastinen, 2011). Recently, massively parallel reporter assays 
(MPRAs) have become a popular HT tool to move beyond statistical association and 
directly measure the impact that single DNA variant has on reporter activity (Tewhey et 
al., 2016). These types of studies that seek to link GWAS variants (and other DNA 
variants such as somatic mutations suspected to drive cancer development) with gene 
expression changes however do not explain the mechanism through which these variants 




 Assaying the effects of a DNA variant on the binding of a TF or the subsequent 
recruitment of a higher-order gene regulatory complex is comparatively a more difficult 
task than associating variants with gene expression changes. Methods such as EMSA 
exist to study protein-DNA interaction and can be used to study the mechanistic effects of 
a variant on protein binding (Hellman and Fried, 2007) but is intractable to perform 
larger scale analyses on variants of interest. Larger scale analysis techniques that use 
ChIP-seq data exist to study the effects of different alleles on the binding of a TF exist 
(Harley et al., 2018; Van De Geijn et al., 2015) but only one TF or chromatin feature can 
be investigated at a time. These allelic imbalance approaches are therefore not suitable 
for more discovery-based work which is the nature of trying to uncover potential 
molecular mechanisms for GWAS and/or disease-associated variants. To address the 
widening gap between studies performed to uncover these variants and those performed 
as functional follow-ups, there is a need for more high-throughput and discovery-based 
methods to study the link between DNA variants and protein-DNA binding. 
1.4 Transcriptional cofactors – linking DNA variants and TFs to gene regulatory 
activities 
 As altered TF binding alone is thought to be an underlying molecular mechanism 
of only a fraction of disease-associated DNA variants (Farh et al., 2015), there must be an 
alternate (or several) mechanism(s) to functionally explain why a given variant can affect 
the expression of a gene. A potential explanation could be that the allosteric effect of a 
DNA variant could affect the optimal recruitment of a COF complex without itself 




the finding that though disease-associated variants often do not occur within a known 
DNA-binding motif, they often appear proximal (Farh et al., 2015). 
 COFs are thought of as the effectors of gene expression change as they have 
enzymatic activities that mediate diverse gene regulatory functions such as histone 
modification, chromatin remodeling, as well as formation of the transcription 
preinitiation complex (Reiter et al., 2017; Shlyueva et al., 2014;, Zabidi and Stark, 2018, 
Haberle and Stark, 2018). An example of a COF with a critical function in gene 
regulation is the coactivator p300 (Goodman and Smolik, 2000; Gerritsen et al., 1997). 
Though it is often thought of as a histone acetyltransferase, it has been shown to confer 
acetyl groups to many additional proteins in a gene regulatory context (Weinert et al., 
2018). P300 is a key activator widely found at enhancers (Raisner et al., 2018) and 
known to be recruited to DNA through protein-protein interactions with DNA-bound TFs 
through various interaction domains (Vo and Goodman, 2001). The p300 example 
demonstrates several general principles of the transcriptional COFs; they are 
promiscuously recruited by diverse TFs and since they are recruited to DNA indirectly, 
their sequence specificity is conferred by the TFs with which they interact (Zabidi and 
Stark, 2016; Haberle and Stark, 2018; Reiter et al., 2017). Though COFs are thought of as 
the components with effector function, focus has traditionally been placed on TFs with 
massive international efforts and community resources dedicated to understanding their 
binding preferences (Feingold et al., 2004) though TF binding alone does not necessarily 
result in known function (MacQuarrie et al., 2011) and COFs are known in turn to 




 As the binding preferences of COFs have been historically understudied 
compared to TFs, the potential role of perturbed COF recruitment at disease-associated 
DNA variants is not completely understood (Lee and Young, 2013). In addition, 
consistent with the current methods to profile the role of DNA variants in TF binding, the 
methods that exist to profile COF recruitment are not suited for the analyses that need to 
be performed to associate DNA variants with altered COF recruitment or TF-COF 
complex formation. Similar to TFs, ChIP-seq can also be used to determine the genome-
wide COF recruitment locations of a COF of interest. Methods to examine allelic 
imbalance however are impractical (as discussed above) and would not suggest a 
complete mechanism. For example, measuring perturbed COF recruitment at a locus 
would not indicate which TF or TF(s) is/are involved. The approach also requires the 
variant to naturally occur in the population of cells being studied. In comparison, 
techniques such as yeast two-hybrid (Y2H) (Kohalmi et al., 1998) and mammalian two-
hybrid (M2H) (Riegel et al., 2017) can precisely map the interactors of a COF of interest 
but these techniques are limited to assaying binary protein-protein interactions and are 
not suited for analysis involving single DNA variants. The related immunoprecipitation 
mass spectrometry (IP mass spec) identifies the TFs that interact with a COF but does not 
explicitly assay DNA-bound complexes (Mohammed et al., 2016). Despite the 
availability of these methods, there does not currently exist any methods to interrogate 





1.5 The need for new cell-based allelic-resolution COF recruitment profiling and 
analysis techniques 
 Our inability to mechanistically explain why a DNA variant correlates with a 
disease outcome and the unstudied potential role of higher order protein-DNA complexes 
(Lee and Young, 2013) suggest that the current methods available are not suited to study 
the impact of single nucleotide variants on COF recruitment in a cell-specific manner. 
 As many of the potential COF recruitment requirements, such as nuclear 
localization, PTMs, and auxiliary TFs, depend on the cellular context (Zabidi and Stark, 
2016; Haberle and Stark, 2018; Reiter et al., 2017), in vitro methods would potentially 
miss important COF recruitment events or provide misleading or incorrect results. New 
methods and investigations into the role of DNA variants in the recruitment of COFs (or 
the assembly of higher order TF-COF complexes) should therefore strive to be more cell-
based. However, cell-based assays, such as ChIP-seq for example, require that the variant 
or variants being interrogated exist naturally within the cells being assayed which is not 
always possible or realistic. An ideal new method to screen the effects of DNA variants 
on the recruitment of gene regulatory complex would thereby combine the advantages of 
both in vitro and cell-based modalities as is the case with MPRAs and gene expression 
(Tewhey et al., 2016). In order to bridge the gap between DNA variant association with 
disease and causal mechanism, new allelic resolution COF recruitment profiling 
techniques must be developed and combine a more cellular context with the 




1.6 Introduction to the novel methods developed for this dissertation 
 Motivated by the lack of methods to profile the nucleotide determinants of 
regulatory complex binding, this dissertation proposes three related methods to perform 
these analyses in a cell-based but highly customizable manner in terms of the DNA 
sequences being profiled. 
 In Chapter 2, we discuss the development of the nuclear extract protein-binding 
microarray (nextPBM) as an extension of the traditional PBM. In place of tagged or 
purified proteins, nextPBM profiles protein-DNA binding from whole nuclear extract. 
This allows researchers to characterize the binding of a protein of interest in the presence 
of possible cooperative-acting factors at their relative endogenous levels and with cellular 
their PTMs present. We use the nextPBM platform to characterize binding of myeloid 
LDTF PU.1 from nuclear extracts compared to in vitro transcribed/translated (IVT) at 
both its canonical binding sites as well as the composite PU.1-IRF8 binding site. We 
leverage the customizability of the DNA probes included to elucidate site- and context-
specific single nucleotide binding preferences of PU.1 and the PU.1-IRF8 cooperative 
complex to these different sites. We propose nextPBM as a general purpose protein-DNA 
binding assay that combines the flexibility of a customizable in vitro system with a more 
biologically relevant profiling context. 
 In Chapter 3, we present CASCADE (Comprehensive Assessment of Complex 
Assembly at DNA Elements). With CASCADE, we extend the nextPBM platform from 
profiling TF-TF cooperative complexes to profiling indirect recruitment of COFs from 




CASCADE can be used to profile the nucleotide determinants of COF recruitment to 
both large CREs as well as known functional single-nucleotide polymorphisms (SNPs) in 
myeloid cells. By comparing the COF recruitment models to previously characterized 
binding models, we infer the identity of TFs underlying COF recruitment events observed 
demonstrating how CASCADE can be used to characterize TF-COF binding. 
Importantly, we show how a 2-step approach that includes CASCADE can be used to 
rapidly screen the mechanistic effects of functional SNPs on TF-COF 
binding/recruitment in a cell- and stimulus-dependent manner thus providing the field 
with an HT assay to characterize SNPs. 
 In Chapter 4, we present the human transcription factor (hTF) array as a 
standardized array design to profile the recruitment of COFs to a diverse panel of TFs. To 
analyze results of these COF recruitment experiments, we designed a full software suite 
complete with an interactive user interface to enable researchers to explore their TF-COF 
binding data. In addition, we discuss the construction of cell state-level recruitment 
“signatures” and how these could eventually be used to study the TF-COF complexes 
active in disease cell states to inform COF- and TF-level biomarkers. 
 In Chapter 5, we conclude this work by summarizing the advances presented by 
the development of these three novel methods (nextPBM, CASCADE, and the hTF array) 
and outline future work. With plans to expand our approaches to characterize more COFs 
and further integrate our COF profiling measurements with other modalities, we hope to 









CHAPTER TWO: nextPBM - a platform to study cell-specific transcription factor 
binding and cooperativity 
Note: A substantial portion of this chapter was previously published in a peer-reviewed 
journal (Mohaghegh et al., 2019) with Nima Mohaghegh (NM) and David Bray (DB) 
featured as co-first authors and equal contributors. The optimized nuclear extraction 
protocol that made the nextPBM technique possible was developed by NM with input 
from Trevor Siggers (TS) and DB. DB performed all of the computational work including 
the design and analysis of all ChIP-seq experiments, selection of DNA probes to include 
in the pilot nextPBM design, development of the nextPBM analysis and visualization 
pipelines, and the generalizable framework to discover and characterize cooperative TF-
TF complex binding. All experimental work (including ChIP-seq, nextPBM, and 
validation assays) were performed by NM and TS. Individual contributions to the results 
outlined in each figure are included in the corresponding figure legend. The manuscript 
was written by DB, NM, and TS.  Supplementary data published alongside the paper can 
be found in the online version of the article. 
 
2.1 Abstract 
 HT in vitro methods for measuring protein-DNA binding have become invaluable 
for characterizing TF complexes and modeling gene regulation. However, current 
methods do not utilize endogenous proteins and, therefore, do not quantify the impact of 
cell-specific PTMs and cooperative cofactors. We introduce the HT nextPBM (nuclear 
extract protein-binding microarray) approach to study DNA binding of native cellular 




and phosphatase treatment steps into our nextPBM pipeline to characterize the impact of 
cofactors and phosphorylation on TF binding. We analyze binding of PU.1/SPI1 and 
IRF8 from human monocytes, delineate DNA-sequence determinants for their 
cooperativity, and show how PU.1 affinity correlates with enhancer status and the 
presence of cooperative and collaborative cofactors. We describe how nextPBMs, and 
our accompanying computational framework, can be used to discover cell-specific 
cofactors, screen for synthetic cooperative DNA elements, and characterize TF 
cooperativity. 
2.2 Introduction 
 Defining the principles that govern TF binding and the assembly of multi-protein 
TF complexes remains a challenge (Siggers and Gordân, 2014; Slattery et al., 2014). HT 
in vitro techniques (both microarray- and sequencing-based) exist to characterize the 
DNA binding of TFs (Slattery et al., 2014; Andrilenas et al., 2015) and cooperative TF 
complexes (Siggers et al., 2011; Slattery et al., 2011; Jolma et al., 2015). Current 
approaches assay the binding of purified or in vitro produced protein samples (Slattery et 
al., 2011; Berger et al., 2006; Badis et al., 2009), or tagged protein overexpressed in cells 
(e.g. HEK293) (Jolma et al., 2013; Fang et al., 2012). Consequently, these approaches do 
not assay the impact of cell-specific PTMs, which are known to have diverse effects on 
TF binding and function (Tootle and Rebay, 2005; Filtz et al., 2014), and do not account 
for the impact of cell-specific cofactors that can bind cooperatively with TFs. 
 To characterize cell-specific TF binding features and account for the impact of 




microarrays that allow in vitro measurement of protein binding to tens of thousands of 
unique DNA sequences (Berger et al., 2006). NextPBM extends the PBM methodology 
by using total nuclear extracts in place of purified, IVT, or over-expressed proteins 
(Materials and Methods). To test the impact of specific cofactors and PTMs on binding, 
we have developed immune-depletion and phosphatase treatment steps into our nextPBM 
pipeline. We describe a computational framework based on binding to single-nucleotide 
variant (SNV) sites that provides a powerful approach to study DNA-binding specificity 
and protein cooperativity when assaying heterogenous NEs. We use nextPBMs to analyze 
the DNA binding of the myeloid cell-lineage factors PU.1 and IRF8, and discuss our 
results. We outline how nextPBMs can be used to discover cooperative TF binding and to 
infer the identity of cooperative-acting factors. Finally, we demonstrate how nextPBMs 
can be used to screen for cooperatively bound synthetic DNA elements. NextPBMs are 
an extendible and robust HT method to assay the binding of proteins to genomic or 
synthetic sites that can capture the impact of cell-specific cofactors and PTMs on TF-
DNA binding. 
2.3 Results 
2.3.1 Genome-wide binding of PU.1, C/EBPa, and IRF8 in a human monocyte line 
 To demonstrate the nextPBM approach, we examined binding of PU.1/SPI1 from 
human monocytes as a test case. PU.1 is a master regulator of the myeloid lineage 
(Nerlov and Graf, 1998; Rosenbauer and Tenen, 2007; Scott et al., 1994) and functions to 
establish localized histone modifications that define the cell-specific enhancer repertoire 




bind DNA autonomously to 5’-GGAA-3’ ETS motifs, or cooperatively with IRF8 to 5’-
GGAANNGAAA(C/G)-3’ ETS-IRF composite elements (EICEs) (Rehli et al., 2000; 
Eklund et al., 1998; Merano et al., 1999). In order to select PU.1 binding sites to examine 
using our nextPBM assay, we first sought to determine the in vivo genomic instances of 
these sites. To define the PU.1 binding landscape in human monocytes, and co-
occupancy with cofactors, we performed ChIP-seq on PU.1, C/EBPα and IRF8 in resting 
THP-1 cells (Materials and Methods). We observed widespread binding for each factor 
and significant overlap in their binding profiles (Fig. 2.1A), consistent with previous 
studies (Ghisletti et al., 2010; Heinz et al., 2010; Langlais et al., 2016; Mancino et al., 
2015). We identified 47,799 PU.1, 26,648 C/EBPα and 2,588 IRF8 binding loci (i.e., 
ChIP-seq peaks) in resting THP-1 cells. The number of PU.1 binding sites is consistent 
with numbers reported for human peripheral blood monocytes (Pham et al., 2012) and 
mouse macrophages (Ghisletti et al., 2010; Heinz et al., 2010; Mancino et al., 2015). 
Critically, we observed near complete overlap of IRF8 binding sites (95%) with PU.1 
binding sites, supporting the model that in vivo IRF8 must bind as a complex with PU.1 





Figure 2.1: Genome-wide binding for PU.1, C/EBPα and IRF8 in human monocytes 
(A) Overlap of genome-wide ChIP-seq peaks discovered for PU.1, C/EBPα, and IRF8. De novo 
motifs discovered within each PU.1-containing intersection are shown on the right. Numbers in 
brackets indicate the percentage of peaks containing the de novo motif (left) compared to 
background (right). Grey bars in the motif logos represent bit values of 0 (bottom), 1 (middle), 
and 2 (top). When a ChIP-seq peak overlapped multiple peaks from another experiment we 
aggregated them into a single overlapping region. (B) Distributions of motif scores obtained for 
ChIP-seq peaks categories described in (A). ChIP-seq peaks were scanned with each motif and 
assigned the maximum log-odds score (see Materials and Methods). Contributions: ChIP-seq 
experiments were designed by NM, DB, and TS and performed by NM. ChIP-seq analysis and 





 To characterize the DNA sequence motifs that define PU.1, C/EBPα and IRF8 
binding we performed de novo motif analysis on defined subsets of the bound genomic 
loci (Materials and Methods). Binding motifs determined for genomic loci bound by 
PU.1 alone or with other factors agree well with known motifs (Fig. 2.1A). At loci bound 
by PU.1 alone we identify a canonical PU.1 binding motif. At loci shared with IRF8 (or 
IRF8 and C/EBPα) the dominant motif is the EICE bound cooperatively by IRF8 and 
PU.1. At loci bound with C/EBPα we identify a PU.1 motif, supporting the idea that 
collaboration between these factors is not via direct cooperative DNA binding but rather 
through synergistic effects on chromatin (Feng et al., 2008; Ghisletti et al., 2010). We 
find that the PU.1 motif identified on loci co-occupied with C/EBPα is slightly more 
degenerate than for PU.1 alone, suggesting that PU.1 binding sequences may be lower 
affinity at loci shared with C/EBPα. 
 To determine the specificity of TF motifs for their respective in vivo binding 
profiles we scored bound regions using the individual TF motifs (Fig. 2.1B). For both 
PU.1 and C/EBPα we observe that their binding motif is highly predictive of their ChIP-
seq peaks. However, for both TFs, motif scores are lower for loci bound with the other 
factors. For IRF8, we find that the EICE motif scores are much higher for IRF8 ChIP-seq 
peaks than for peaks from other factors. These analyses demonstrate that motifs identified 
for each TF are specific for their genomic binding loci, and that TF binding at loci co-




2.3.2 Nuclear extract protein-binding microarrays (nextPBM) 
 To define PU.1 binding sites for our nextPBM assay (Fig. 2.2A), we selected 
2,499 DNA sites in ChIP-positive regions that matched a PU.1 PWM (Materials and 
Methods, Supplementary File 1 from Mohaghegh et al., 2019). To identify composite 
PU.1-IRF8 EICE elements, we selected 116 EICE sites from regions bound by both PU.1 
and IRF8. Nuclear extracts from human THP-1 monocyte cells were made using a 
detergent-based cell lysis and extraction procedure and incubated with the double-strand 
DNA microarrays (Materials and Methods). As proteins in the assay are not epitope-
tagged, primary antibodies were used to label PU.1, followed by fluorescently labeled 





Figure 2.2: Nuclear extract protein-binding microarrays (nextPBMs) 
(A) Workflow schematic for the nextPBM protocol. (1) Cultured cells can be stimulated or 
treated with a drug prior to nuclear extraction. (2) Total soluble protein content is harvested from 
cell nuclei using an optimized protocol (see Materials and Methods). (3) Nuclear extract can be 
treated in parallel enzymatically (i.e. by phosphatase treatment) and components of interest can 
be depleted (i.e. by immune-depletion using a targeted antibody) depending on goals of the 
experiments. (4) DNA binding affinity of one or more transcription factors of interest are profiled 
in parallel directly from nuclear extract. (B) Density of PU.1 nextPBM z-scores obtained at 
random background probes (n = 500) and at genomic PU.1 binding sites (n = 2,615). (C) 
Scatterplot of PU.1 binding z-scores obtained by DNA probes corresponding to random 
background (black) and genomic PU.1 sites (blue) in different biological replicates. (D) Left: 
Schematic representation of the SNV probes corresponding to an example PU.1 seed probe. 
Genomic sequence corresponding to the PU.1 motif is highlighted in sky blue within a larger 
20bp sequence. SNVs within a given SNV probe are shown in dark blue. Right: Sequence logos 
obtained for the same genomic PU.1 seed probe using a PU.1 antibody (top) and an FLI1 
antibody (bottom). Δz-scores are computed relative to the median score obtained within a given 
column. Contributions: nextPBM workflow was developed jointly by NM, DB, and TS. NM and 
TS performed the nextPBM experimental work. nextPBM microarray design, analysis, and 
visualization pipelines were developed by DB with input from TS. 
 
 PU.1 binding was detected to genome-derived sites significantly above 
background sites (Fig. 2.2B), demonstrating that there is sufficient endogenous protein in 
nuclear extracts to quantify TF binding using our assay. PU.1 binding profiles for 
individual replicate experiments were highly correlated, demonstrating high 
reproducibility between nextPBM experiments (Fig. 2.2C). To assess the sensitivity of 
our nextPBM assay, we generated a PU.1 DNA-binding logo using a SNV probe-based 
approach (Materials and Methods) (Andrilenas et al., 2018). Briefly, we measured PU.1 
binding to a 20 bp-long seed sequence and all 60 SNV sequences (Fig. 2.2D); logos were 
generated from binding scores to each SNV sequence (Fig. 2.2D). The PU.1 binding logo 
agreed well with the established ETS-type motif (Wei et al., 2010), demonstrating that we 
can accurately measure the TF binding specificity using nextPBMs. As the nuclear 




the binding of another ETS factor could be assayed in parallel using the same DNA sites. 
Probing the nextPBM with antibodies to FLI1, another ETS factor expressed in THP-1 
monocytes, we were able to define the FLI1 binding motif (Wei et al., 2010) using the 
same seed and SNV probes as used for PU.1. We note that PU.1 and FLI1 are related 
ETS factors and exhibit only minor differences in their DNA binding specificity, namely 
the 2–3 bases upstream of the 5’-GGAA-3’ core element (Fig. 2.2D); however, we were 
able to resolve their distinct motifs in parallel using the SNV approach. These results 
show that robust and sensitive quantification of TF binding can be performed for TFs at 
endogenous levels in heterogeneous nuclear extracts. 
2.3.3 Characterizing the DNA binding of PU.1 and IRF8 in monocytes using nextPBM 
 To identify monocyte-specific features of PU.1 binding, we compared monocyte 
nextPBM data for PU.1 with binding data using IVT PU.1 (Fig. 2.3A). Binding to 
genomic PU.1 sites was highly correlated between extract PU.1 and IVT PU.1 (Fig. 2.3A, 
highlighted in blue); however, binding of extract PU.1 was enhanced to the EICEs 
present in genomic regions co-occupied by PU.1 and IRF8 (Fig. 2.3A, highlighted in 
red). We confirmed that IRF8 was also bound to the EICE sites using an IRF8 nextPBM 
(Fig. 2.3B). IRF8 binds almost exclusively to the EICEs, consistent with the known 
requirement for cooperative binding with PU.1 in monocytes. The enhanced PU.1 
binding to EICEs (Fig. 2.3A) suggests cooperative binding with a monocyte-specific 
cofactor. These results demonstrate that using nextPBMs to compare the TF binding 
profiles from nuclear extracts and purified/IVT protein provides a HT approach to 









(A) Scatterplot of PU.1 binding z-scores obtained from nuclear extract (nextPBM) versus IVT 
PU.1 for random background probes (n = 500), EICE probes (n = 116), and canonical PU.1 
probes (n = 2,499). (B) Scatterplot of IRF8 binding z-scores in nuclear extract versus PU.1 
binding z-scores in nuclear extract for the same sets of probes as in (A). (C) Left – scatterplot of 
PU.1 binding z-scores in nuclear extract versus IVT PU.1 for probes included in (A) and SNV 
probes corresponding to the EICE seed probe shown right. Highlighted probes correspond to 
SNV probes containing variations in either the ETS core half-site (blue), IRF core site (red), or 
flanking and linker bases (yellow). Right - schematic of EICE seed probe and bases comprising 
individual sub-elements. (D) Sequence logos obtained using a canonical PU.1 seed probe (left 
column) and a cooperative ETS-IRF composite element (EICE) probe (right column) from 
nuclear extract (top row) and from IVT PU.1 (bottom row). (E) Workflow schematic for 
identifying cooperative binding sites using nextPBM. 1 – ChIP-seq sites for a given transcription 
factor of interest (TF1) can be sampled and used to construct probes for a microarray design. The 
sample will contain sites where TF1 is cooperatively bound with other factors. 2 – TF1 sample 
probes are combined with a set of random background probes against which binding z-scores are 
computed to form the basis of a microarray design. 3 – Profiling binding of TF1 in nuclear extract 
versus IVT allows for the discovery of cooperative binding sites bound higher in nuclear extract 
(shown above the diagonal). 4 – Cooperative sites identified can be used as seed probes in a 
subsequent experiment where SNV probes are included in the microarray and profiled. 5 – 
Binding to SNV probes is used to model and compare seed- and context-specific DNA binding 
preferences of TF1 to identify composite elements and likely binding partners. Contributions: 
nextPBM experimental work was performed by NM and TS. nextPBM design, analysis, and 
visualization pipelines were developed by DB with input from TS. 
 
2.3.4 Defining DNA-sequence determinants of PU.1-IRF8 cooperativity 
 To examine determinants of PU.1-IRF8 cooperativity we visualized the impact of 
SNVs on PU.1 binding (Fig. 2.3C). We highlighted SNVs that occur in different regions 
of an EICE site: ETS/PU.1 half-site (blue); IRF half-site (red); flanking and linker 
sequence (yellow) (Fig. 2.3C). SNVs in the ETS half-site abrogate PU.1 binding for both 
IVT and nuclear extract samples as expected (Fig. 2.3C, blue). SNVs in the IRF half-site 
affect the cooperative binding but do not affect the binding of IVT PU.1, capturing the 
impact of IRF8 present in the extract samples (Fig. 2.3C, red). SNVs in the flanking and 
linker sequence affect PU.1-IRF8 complex affinity but largely do not abrogate the 




demonstrating that cooperative binding does not require specific sequence features 
outside of the core half-sites (Fig. 2.3C, yellow). This analysis highlights that nextPBMs 
can be used to dissect the determinants of cooperativity for a single DNA binding site. 
 Binding specificity can also be visualized as DNA-binding logos, providing a way 
to easily reveal binding differences to distinct classes of DNA sites under different 
sample conditions (Fig. 2.3D). PU.1 binding logos generated for a seed sequence that was 
not bound cooperatively match canonical PU.1 logos for both the nuclear extract and IVT 
experiments (Fig. 2.3D, left). In contrast, the PU.1 binding logos for a cooperatively 
bound seed sequence differ between the conditions: the logo from the nuclear extract 
experiment resembles the composite EICE element, showing the influence of the IRF8 
binding, while the logo from the IVT experiment shows just the PU.1 logo (Fig. 2.3D, 
right). We note that we obtain consistent motifs when using other high-scoring seed 
sequences (Supplementary Fig. 2.3 and Supplementary Fig. 2.4). The impact of cofactors 
on binding to the distinct classes of DNA sites can be easily visualized using SNV-based 
logo analysis. Using this approach we can analyze multiple TF binding modes in parallel 
in a single experiment (i.e., the PU.1 logos for cooperative and non-cooperative binding 
were determined using a single experiment). 
2.3.5 Approach to identify and characterize cooperative binding 
 Our results provide an approach for the identification and characterization of cell-
specific cooperative binding (Fig. 2.3E). Briefly, putative DNA binding sites of a TF can 
be identified from genomic data (e.g. ChIP-seq combined with motif analysis, etc.) or be 




nextPBM microarray (Fig. 2.3E, steps 1 and 2). For example, scanning PU.1 ChIP-seq 
data with a PU.1 PWM with relaxed cutoff scores can be used to identify both 
autonomous and cooperatively bound sites. Next, comparison of binding profiles between 
nuclear extract and purified TF experiments can be used to identify cooperatively bound 
sites (Fig. 2.3E, step 3). Based on this data, one can design SNV probes for target DNA 
sites and perform a follow-up nextPBM experiment to define DNA-binding logos that 
reveal the cooperative binding specificity and provide information about the identity of 
cooperatively acting factors. For example, monitoring PU.1 binding revealed the 5’-
GAAACT-3’ IRF logo (Fig. 2.3D), which could be matched to PWMs from databases to 
make predictions about the PU.1 cooperative binding partner. The outlined approach 
provides a HT assay to identify and characterize cooperative TF complexes in a cell-
specific manner. 
2.3.6 Sensitivity of cooperative binding to nuclear extract concentration 
 To test the sensitivity of our results on nuclear extract concentration, we 
performed nextPBM experiments at successive dilutions of monocyte nuclear extract. We 
quantified PU.1 cooperativity as the off-diagonal displacement of the 116 EICE sites 
from the autonomously bound PU.1 sites (as in Fig. 2.3A, Materials and Methods). We 
found that PU.1-IRF8 cooperativity decreased with decreasing extracts concentrations 
(Fig. 2.4A). We also assessed cooperativity by monitoring the PU.1 DNA binding logo 
for an EICE site as extract concentration varied. We observed a consistent PU.1 element 
(i.e. 5’-GGAA-3’ core) with a successively weaker IRF8 element (i.e., 5’-GAACT-3’) 




both the bound PU.1 and PU.1-IRF8 complexes contribute to the microarray spot 
intensity in a PU.1 nextPBM. Therefore, observing PU.1 cooperativity requires that the 
increase in spot intensity due to the presence of PU.1-IRF8 complexes must be discerned 
beyond the signal intensity from PU.1 binding alone, leading to the observed 
concentration dependence in our assay. In contrast, IRF8 is an obligate dimer in this 
context; therefore, all signal in an IRF8 nextPBM is due to PU.1-IRF8 complexes. As 
such, the binding logos for an IRF8 nextPBM are much more robust to extract 
concentrations and we can discern cooperative EICE logos for all extract concentrations 
(Fig. 2.4B, right). The results demonstrate that the concentration dependence of 






Figure 2.4: Effects of different nuclear extract treatments on PU.1-IRF8 cooperative 
binding 
(A) Boxplot of PU.1-IRF8 cooperativity scores (see Materials and Methods) for a set of EICE 
probes (n = 116) in various listed nuclear extract (NE) conditions and treatments including a 
gradient of 2-fold dilutions (1:1, 1:2, 1:4, and 1:8), an extract where IRF8 has been immune-
depleted (IRF8 immune-depletion), an extract treated with a broad-spectrum phosphatase 
(phosphatase), and an extract generated from a line of cells where IRF8 has been knocked out 
(IRF8 CRISPR KO). Boxplot elements – center line: median, box limits: first and third quartiles, 
whiskers: 1.5x interquartile range, individual points: data points beyond end of whiskers. (B) 
Sequence logos obtained by profiling PU.1 binding (left column) and IRF8 binding (right 
column) to the same sample EICE seed probe in the corresponding nuclear extract 
treatments/conditions from (A). Contributions: nextPBM experimental work including the nuclear 
extract treatments were performed by NM and TS. nextPBM design, analysis, and visualization 
pipelines were developed by DB with input from TS. 
 
2.3.7 Assessing the impact of cofactors and post-translational modifications 
 To determine whether the cooperative PU.1 binding to EICEs was solely due to 




performed nextPBM using nuclear extracts from IRF8-deficient cells. Cooperative 
binding of PU.1 was lost in the absence of IRF8 protein (Fig. 2.4A and Fig. 2.4B, 
bottom), consistent with reduced PU.1 ChIP-seq to EICEs reported for Irf8-null mouse 
macrophages (Mancino et al., 2015). CRISPR/Cas9-based deletion of target TFs remains 
a labor-intensive process; therefore, we sought to develop a more rapid approach for 
testing the impact of cofactors on cooperative TF binding. We developed an immune-
depletion protocol to deplete a TF from the nuclear extracts in the nextPBM pipeline 
(Fig. 2.2A). NextPBM with IRF8-depleted extracts showed similar abrogation of the 
enhanced PU.1 binding (Fig. 2.4A and Fig. 2.4B), corroborating the CRISPR/Cas9-based 
results that IRF8 is solely responsible for PU.1 cooperativity. Our depletion step removed 
>90% of the IRF8 from the extract sample (Supplementary Fig. 2.5); however, an IRF8 
nextPBM was still successful and we were able to generate an EICE logo, demonstrating 
that for obligate heterodimers such as IRF8, cooperative binding can be detected even 
with low levels of protein in the extract. NextPBM with an immune-depletion treatment 
provides rapid assay for the impact of cofactor proteins on cooperative TF complexes. 
 PTMs play a central role in the regulation of TF function and cooperative TFs 
complexes in vivo. Cooperative binding of PU.1 and IRF8 has been reported to involve 
phosphorylation of IRF8 (Sharf et al., 1997). To test the impact of phosphorylation on 
PU.1 cooperativity we incubated our extract sample with a broad-spectrum phosphatase 
prior to the nextPBM (Fig. 2.2A, Supplementary Fig. 2.6, Materials and Methods). 
Phosphatase treatment of our extract samples abrogated PU.1 cooperative binding to the 




phosphorylation. The disruption of cooperative binding can also be seen in the PU.1 
binding logo as an absence of the IRF8 half-site (Fig. 2.4B). We note that this treatment 
had no effect on autonomous PU.1 binding. Therefore, nextPBM with an enzymatic 
treatment of the extract provides a rapid assay for the PTM-dependence of TF binding to 
diverse DNA sequences.  
2.3.8 Screening synthetic DNA elements for cooperative binding 
 NextPBMs present an opportunity to screen synthetic DNA elements (i.e., mutant 
or novel sequences) for cooperative TF binding in a more cell-native context that may be 
used to probe the rules of cooperativity or to design synthetic genetic regulatory 
elements. We first tested our ability to screen for the impact of half-site ablations on 
cooperative binding. We compared the binding of PU.1 and IRF8 to 60 EICE elements 
and matched mutants with an ablated ETS or IRF site (Fig. 2.5A and Fig. 2.5B). Mutating 
the ETS half-site abrogates PU.1 binding, whereas mutating the IRF half-site only affects 
the observed cooperativity (Fig. 2.5B). In contrast, IRF8 binding is abrogated with 
mutations to either the ETS or the IRF half-site (Fig. 2.5C). These results demonstrate 
that IRF8 binding is dependent on cooperativity with PU.1, but not vice versa, consistent 
with observations in vivo (Rehli et al., 2000; Eklund et al., 1998; Merano et al., 1999). 
We next tested our ability to screen for new cooperative sites and generated 199 synthetic 
EICEs by combining low-affinity PU.1 sites with a consensus IRF8 site (Fig. 2.5A). An 
adjacent IRF8 site greatly enhanced PU.1 binding to all sites in the presence of the 
nuclear extract but not for IVT PU.1 (Fig. 2.5B). Similarly, IRF8 bound strongly to these 




NextPBMs provide a platform for HT screening of DNA sequences for cooperative 
binding that can account for the impact of the native cell-specific protein environment. 
 





(A) Schematic showing representative probe sequences and corresponding mutated elements. For 
each genomic EICE from active enhancers in our array design (n = 60), there is a corresponding 
probe with the ETS and IRF core sites independently mutated to contain a different k-mer. For 
each canonical PU.1 probe with a weak motif (n = 199), there is a corresponding probe with an 
IRF half-site added. (B) Distributions of PU.1 binding z-scores for DNA probe groups in (A) in 
nuclear extract (blue) compared to IVT. BG – random background probe set (n = 500). Boxplot 
elements – center line: median, box limits: first and third quartiles, whiskers: 1.5× interquartile 
range, individual points: data points beyond end of whiskers. (C) Distributions of IRF8 binding z-
scores to the same DNA probe groups as in A and B. Boxplot elements: same as in (B). (D) 
Distributions of PU.1 binding z-scores for DNA probe categories defined by ChIP-seq co-
occupancy with cofactors (PU.1 binding context) and/or histone modifications (enhancer state). 
‘NOT MARKED’ indicates the absence of H3K4me1 and H3K27ac histone modifications. 
‘SINGLE REP’ designates a category of probes designed using PU.1 ChIP-seq peaks that were 
discovered in a single biological replicate but were not observed in a duplicate experiment. The 
dashed black line denotes an approximate ChIP-seq reproducibility threshold corresponding to 
the median z-score obtained for the PU.1 SINGLE REP group in IVT. Boxplot elements: same as 
in (A) and (B). Contributions:  Integrative genomics analyses and categorization of PU.1 sites 
was performed by DB with input from TS. nextPBM experimental work was performed by NM 
and TS. nextPBM design, analysis, and visualization pipelines were developed by DB with input 
from TS. 
 
2.3.9 Binding affinity of PU.1 correlates with enhancer state and cofactor occupancy 
 To examine how nextPBM data can inform genomic analysis of TF binding, we 
examined PU.1 binding to sites from genomic regions defined by distinct chromatin 
states and cofactor occupancy. In addition to IRF8, PU.1 functions with C/EBPα to bind 
chromatin and establish macrophage-specific genes expression (Heinz et al., 2010; Feng 
et al., 2008; Laiosa et al., 2006; Xie et al., 2004). PU.1 does not bind DNA cooperatively 
with C/EBPα; rather they function collaboratively through mutual effects on repressive 
chromatin environments. We performed ChIP-seq on C/EBPα and identified PU.1 
binding sites in regions co-occupied by both PU.1 and C/EBPα, or by all three factors 
(PU.1, C/EBPα and IRF8) (Fig. 2.1A). To examine the relation between chromatin state 




poised (H3K4me1 only) and active (H3K4me1 and H3K27ac) enhancer states 
(Heintzman, et al., 2007; Creyghton et al., 2010). 
 We first examined PU.1 binding to distinct enhancer states: primed, active, or 
unmarked (no H3K4me1 or H3K27ac marks) (Fig. 2.5D). To control for the effect of 
cofactors we limited our analysis to sites from PU.1-only occupied regions. PU.1 binding 
affinity shows a clear trend with enhancer state. High-affinity PU.1 binding to unmarked 
loci is in agreement with previous studies (Pham et al., 2013) and suggests that PU.1 
occupancy to less biophysically accessible chromatin regions requires high-affinity sites. 
Low-affinity PU.1 binding in active enhancers reveals that functional PU.1 sites are not 
the highest affinity, and that genome-wide analyses of the highest affinity TF sites may 
be enriched for non-functional binding. Binding to all sites agrees between the nuclear 
extract and IVT samples, suggesting that there is no influence of cooperative binding to 
these genomic elements and that the binding trends are defined by autonomous PU.1 
binding. 
 We next examined PU.1 binding at active enhancers co-occupied by collaborative 
(C/EBPα) or cooperative (IRF8) cofactors (Fig. 2.5D). We observe a clear trend in 
affinity for the PU.1 IVT data that suggests an impact of cofactors on PU.1 binding. First, 
PU.1 binding sites are lower affinity in regions co-occupied by either cofactor than in 
regions occupied by PU.1 alone (Fig. 2.5D). For example, in regions co-occupied with 
C/EBPα, PU.1 binding sites have Δz-scores ∼ 0.5 lower than for PU.1-only regions (P-
value < 0.001), and in regions co-occupied with IRF8 the affinity is even lower (Δz-score 




(C/EBPα and IRF8) PU.1 binding is the lowest affinity (Δz-score ∼ 2.5, P-value < 
0.001), suggesting that the effects of collaborative and cooperative cofactors on PU.1 
binding are independent and additive. However, when analyzing the nextPBM data, we 
observe that cooperativity with IRF8 significantly increases the PU.1 binding to EICE 
sites. For perspective, we examined PU.1 binding to sites from genomic regions 
identified as PU.1-bound in only a single ChIP-seq replicate experiment (SINGLE REP), 
which we found to be lower affinity than for reproducible PU.1 ChIP sites. We observe 
that, in the absence of IRF8, PU.1 affinity falls below this ‘reproducible level’, which 
may explain the drop in PU.1 ChIP-seq signal observed in IRF8 knock-out mouse 
macrophages (Mancino et al., 2015). Our results demonstrate that cooperative binding 
with IRF8 or collaborative function with C/EBPα allow PU.1 binding sites to be much 
lower affinity than an optimal site, and highlight the perspective gained by analyzing TF 
binding using both purified/IVT and nuclear extract samples.  
2.4 Discussion 
 HT methods for characterizing TF-DNA binding provide critical biophysical data 
for genomic analyses of gene regulation (Siggers and Gordân, 2014; Slattery et al., 2014; 
Andrilenas et al., 2015). Cell-specific PTMs (Tootle and Rebay, 2005; Filtz et al., 2014) 
and cofactors (Siggers and Gordân, 2014; Garvie and Wolberger, 2001) can affect TF 
binding, but are not implicitly accounted for in current HT methods. Here we describe the 
nextPBM methodology for the characterization of protein-DNA binding that uses nuclear 
extracts to account for the impact of cell-specific PTMs and cofactors. We show that a 




can reveal cooperative binding activity and cooperatively bound sites. Using an SNV-
based approach to query sequence specificity and generate binding logos we can examine 
binding and cooperativity for individual genomic sites. The flexibility to analyze binding 
specificity for individual sites allows multiple binding modes to be directly studied in 
parallel in a single experiment. This approach is analogous to the seed-and-wobble 
approach previously described for universal PBMs that quantify TF binding to k-mers 
(Berger et al., 2006). We note that DNA shape is known to play an important role in TF 
binding specificity (Andrabi et al., 2017; Zhou et al., 2015; Yang et al., 2014), and future 
studies that examines the role of DNA shape in the context of multi-protein complexes 
and cell-specific extracts will be informative. We anticipate that this approach will be 
particularly useful when studying TFs that function as obligate heterodimers and may 
have multiple binding partners in a complex nuclear extract and, therefore, interact with 
DNA using distinct binding modes. To address the impact of cofactors and 
phosphorylation on TF binding we have incorporated immune-depletion and 
phosphatase-treatment steps into our nextPBM pipeline. Incorporation of additional 
enzymatic treatment steps will allow us to expand our assay to study other PTMs (e.g., 
demethylases to study impact of methylation, etc.). NextPBMs provide an extendible 
platform to study the DNA binding of endogenous TF complexes in a cell-specific 
manner. We anticipate that nextPBM-based comparison of cell-specific TF binding and 
cooperative assembly will be particularly informative when applied to comparisons of 




 Our study outlines a new approach to identify cooperative binding TFs and 
cooperatively bound sites. First, by sampling from bound genomic loci identified by 
ChIP-seq experiments, one can design a nextPBM microarray to survey a diverse set of 
binding sites for a TF. Currently, using available microarray platforms (Materials and 
Methods), and accounting for replicate probes, we can assay up to ∼18 000 unique 
genomic sites in an experiment, which is sufficient to thoroughly sample (or even 
completely cover) most TF cistromes. Direct comparison of nextPBM binding profiles 
from nuclear extract and purified protein can then reveal differentially bound DNA sites. 
Enhanced binding in nextPBM experiments indicates potential cooperative binding, and 
by reanalyzing these binding sites with a subsequent SNV-based array design we can 
generate binding logos on a per-site basis that can be used to make predictions about the 
possible cooperative binding partners. The identity of binding partners can then be tested 
using nextPBMs with an immune-depletion step. Using nextPBMs to compare the 
binding profiles of TFs from different cells will be particularly useful for studying the 
TFs that function as obligate heterodimers and may utilize different partner proteins in 
different cell types. While the cooperative complex examined in this manuscript involves 
two proteins (PU.1 and IRF8), this approach can, in principle, be used to examine 
cooperative assembly of more than two proteins as all constituents are available in the 
nuclear extract. We have previously demonstrated that cooperative complexes of more 
than two purified proteins can be assayed using the PBM technology (Siggers et al., 
2011). This approach to identify cooperative binding can also be used to screen novel 




the design and testing of cell-specific cooperative elements that can be used to construct 
synthetic gene regulatory elements for mammalian cells. 
 We examined the binding of PU.1 and IRF8 from human monocytes, and 
identified the known composite EICE binding logos using nextPBMs probing either PU.1 
or IRF8. Using CRISPR/Cas9-based IRF8 knockout and immune-depletion we 
demonstrated that IRF8 is the only cooperative binding partner for PU.1 in human 
monocytes. Investigating the relationship between binding, cooperativity and genomic 
occupancy we found that PU.1 binding affinity exhibits a clear trend with both enhancer 
type and cofactor co-occupancy. We found that the highest affinity PU.1 sites are in 
genomic regions not containing the H3K4me1 and H3K27ac histone modifications for 
active enhancers, and lowest affinity sites are in active enhancers. Furthermore, co-
occupancy with either collaborating (C/EBPα) or cooperative (IRF8) cofactors correlated 
with lower affinity binding sites, suggesting that cofactor occupancy allows for the 
evolutionary selection of lower affinity binding sites. Surprisingly, coincident binding of 
PU.1 with both C/EBPα and IRF8 allowed for still lower affinity sites to be utilized. 
These results highlight that functional binding sites are not the highest affinity, and that 
genomic analyses biased to high affinity may miss functionally relevant sites. 
Furthermore, the nextPBM-based functional characterization of low affinity PU.1 binding 
sites proximal to cooperative and collaborative TF sites in active enhancers supports the 
findings from recent investigations into the genome-wide presence of low affinity PU.1 
sites proximal to other TF binding motifs (Pham et al., 2013) and the discordance 




Andrilenas et al., 2018; Penvose et al., 2019). Finally, comparing binding profiles for 
nextPBM and IVT samples across stratified genomic sites demonstrated that PU.1 
binding was autonomous on all sites except for the EICEs where it was cooperative with 
IRF8. NextPBM-based binding analysis of genome-derived sites provides insights into 
the biophysical determinants of TF binding. We anticipate that similar studies that 
compare TF binding profiles from different cellular conditions will provide new insights 
into the mechanisms of cell-specific binding and gene regulation. 
2.5 Materials and Methods 
2.5.1 Cell culture 
 THP-1 cells were purchased from ATCC (cat # TIB-202) and cultured in RPMI 
1640 media with 10% FBS supplemented by 50 unit/ml Penicillin and 50 μg/ml 
Streptomycin. HEK293T cells for Lentivirus packaging (gift from Thomas Gilmore, 
Boston University) were cultured in DMEM media with 10% FBS supplemented by 50 
unit/ml Penicillin and 50 μg /ml Streptomycin. 
2.5.2 Protein samples 
 IVT samples of PU.1 (full-length, untagged) were generated using 1-Step Human 
Coupled IVT Kit – DNA (Thermo Fisher Scientific cat # 88881) following the provider’s 
instructions. Protein expression was confirmed by Western analysis. 
2.5.3 Antibodies 
 PU.1 (Santa Cruz sc-352x, used for ChIP and nextPBM); C/EBPα (Santa Cruz sc-




H3K4me1 (Abcam ab8895, used for ChIP); H3K27ac (Abcam ab177178, used for ChIP); 
alexa488-conjugated anti-goat (Life Technologies A11055, used for nextPBM); 
alexa647-conjugated anti-rabbit (Life Technologies A32733, used for nextPBM); and 
FLI1 (ABclonal A5644, used for nextPBM) was a gift from ABclonal. 
2.5.4 Plasmids 
 Lentiviral plasmid constructs were prepared following Feng Zhang Lab 
(Massachusetts Institute of Technology) protocol. Briefly, to target IRF8 gene a pair of 
gRNAs were synthesized for exon 5 of the IRF8 gene (Primers: 5’-
CACCGCTTCTGTGGACGATTACATG-3’ and 5’-
AAACCATGTAATCGTCCACAGAAGC-3’) with overhangs and ligated into BsmBI 
digested pLentiCRISPRv2.0. 
2.5.5 Nuclear extracts 
 5 × 106 THP-1 cells were pelleted at 500 × g for 5 min at 4°C in a 15 ml conical 
tube. The pellet was resuspended and washed twice with PBS. Cell pellet was 
resuspended in 1 ml of ‘low-salt buffer’ (10 mM HEPES (pH 7.9), 1.5 mM MgCl2, 10 
mM KCl plus 1 μl protease inhibitor cocktail (Sigma-Aldrich, cat # P8340) and incubated 
for 10 min on ice. 50 μl of 5% IGEPAL (Sigma-Aldrich, cat # I8896) was added to the 
cell suspension and vortexed for 10 seconds. Released nuclei were pelleted at 750 × g for 
5 min at 4°C. The supernatant was saved as the ‘cytosolic fraction’. To wash the 
remaining cytosolic proteins from the surface of the nuclear pellet, 100 μl of the low-salt 




making sure to not disrupt the pellet. This wash was then gently transferred to the 
cytosolic fraction without dislodging the nuclear pellet. 200 μl of ‘high-salt buffer’ (20 
mM HEPES (pH 7.9), 25% glycerol, 1.5 mM MgCl2, 0.2 mM EDTA, 420 mM NaCl plus 
1 μl protease inhibitor cocktail) was pipetted on the pellet and the tube went through a 
vigorous vortex for 30 s followed by nutation at 4°C for 1 h. The nuclei were pelleted at 
4°C for 20 min at 21,000 × g. The supernatant was transferred into another tube as the 
nuclear soluble protein fraction. Final nuclear extract samples used in nextPBM assays 
were 9.6 mg/ml. 
2.5.6 CRISPR-mediated IRF8-knockout in THP-1 cells 
 To generate Lenti-CRISPR viruses, HEK293T cells were seeded in a 10 cm dish 
at 75% confluence a day before transfection. The next day, the confluent cells were co-
transfected with 4μg of pCMV-VSV-G, 2 μg pCMV-ΔR8.91 and 1 μg plentiCRISPR v2- 
gRNA using a Lipofectamin-3000 kit and following the provider’s instructions. The 
transfection mixture was replaced by fresh media after 6 h and the virus-containing 
supernatant was collected after 48 h. Virus was concentrated by ultracentrifugation at 
50,000 × g for 3 h at 4°C. The viral pellet was re-suspended in 500 μl complete medium 
(RPMI, 10% FBS) with 8 μg/ml Polybren and added to one million THP-1 cells in a 
microcentrifuge tube with 1.5 ml of complete media and shaken at 150 rpm for 30 min at 
room-temperature, followed by centrifugation at 850 × g for 30 min at 32°C. The THP-1 
cell pellet was re-suspended in 2 ml of complete medium and was seeded in a 3 cm dish 
and incubated at 37°C with 5% CO2 for 6 days. At day 6, infected cells were selected in 




complete media containing 0.5 μg/ml puromycin every four to six days and for a total of 
30 days. Cell confluence was maintained between 3 × 105 cells/ml to 9 × 105 cells/ml 
through the selection procedure and the culture volume was scaled up as necessary. 
Knockout efficiency in the pool of the infected cells was defined by Western analysis. 
2.5.7 Nuclear extract treatments 
 Immune depletion of IRF8 – 7.5 μg of IRF8 antibody (abcam, ab207418) was 
added to 300 μL of diluted THP-1 nuclear extract (2 mg/ml total protein in nextPBM 
binding buffer (described below), 115 mM NaCl). The mixture was nutated at 4°C for 1 
h. 75 μl of Dynabeads® Protein A slurry (Thermo Fisher Scientific, 10001D) was washed 
once using 1 ml of nextPBM binding buffer with 115 mM salt and collected by DynaMag 
magnet (ThermoFisher Scientific, cat # 12321D). Collected beads were re-suspended in 
the nuclear extract plus antibody mixture and transferred onto HulaMixer (ThermoFisher 
Scientific cat # 15920) to be rotated at 4°C for 2 h at 25 rpm. DynaMag magnet was used 
to collect the beads and the remaining nuclear extract was checked for the depletion of 
IRF8 by Western analysis. Phosphatase treatment – A general phosphatase (Lambda 
protein phosphatase kit, New England Biolabs, p0753) was added to 300 μl of diluted 
THP-1 nuclear extract (2 mg/ml total protein in nextPBM binding buffer (described 
below), 115 mM NaCl), and the reaction was carried out according to the provider’s 
instructions. Phosphatase efficiency was checked by Western analysis for phospho-RNA 




2.5.8 Chromatin immunoprecipitation (ChIP-seq) 
 Soluble chromatin was prepared from 4×107 THP-1 cells according to previously 
described protocols (Lee et al., 2006) with some modifications (outlined below). Briefly, 
cells were crosslinked with 1% formaldehyde (final concentration) (Fisher Scientific, cat 
# F79-500) for 10 min at room temperature with gentle shaking. Crosslinking was 
stopped by adding 125 mM final concentration of glycine solution in PBS. Fixed cells 
were pelleted at 800 × g for 5 min at 4°C and washed twice with 10 ml of cold PBS in a 
15 ml conical tube and pelleted at 800 × g for 5 min at 4°C. Washed cell pellet was re-
suspended in 10 ml of Lysis Buffer 1 (Lee et al., 2006), nutated for 10 min at 4°C, and 
pelleted at 2,000 × g for 5 min at 4°C. The same procedure was repeated with lysis buffer 
2 at room temperature followed by pelleting at 2,000 × g for 5 min at 4°C. To release 
nuclei from hard-to-disrupt THP-1 membranes, cells were re-suspended in 10 ml of Lysis 
Buffer 3 (Lee et al., 2006) and were shaken vigorously (225 rpm) at room temperature for 
30 min. Cells were then passed through an 18-gauge needle (VWR, cat # BD305195) 25 
times using a 10ml syringe. Nuclei were pelleted at 3,000 × g for 20 min at 4°C and re-
suspended in 500 μl of Lysis Buffer 3 and then transferred into a 1.5 ml microfuge tube 
placed in Benchtop 1.5 ml Tube Cooler (Active Motif, cat # 53076). The nuclei were 
sonicated using Active Motif Q120AM sonicator with a 3.2 mm Probe (Active motif cat 
# 53053) at 25% amplitude for 15 min with 20 s ON and 30 s OFF cycles (45 cycles 
total). Cell debris was pelleted at 21,000 × g for 30 min at 4°C. 50 μl of the combined 
soluble chromatin was saved to be used as the input DNA upon reverse-crosslinking. For 




H3K4me1 or H3K27ac antibodies (60 μg of IRF8 antibody was mixed with 1 ml of the 
soluble chromatin), and tubes were rotated at 25 rpm for one hour at 4°C using 
HulaMixer (ThermoFisher Scientific cat # 15920). 125 μl of the protein A Dynabead 
slurry (ThermoFisher Scientific cat # 10001D) per each rabbit antibody (PU.1. C/EBPα, 
H3K4me1 or H3K27ac), and 250 μl of the protein G Dynabead slurry (ThermoFisher 
Scientific cat # 10003D) for the goat-IRF8 antibody, were transferred into 1.5 ml 
microfuges and placed on DynaMag magnet (ThermoFisher Scientific, cat # 12321D) 
until all beads collected on the side of tubes. The solution was gently aspirated off from 
each tube and the beads were re-suspended in 1 ml of the Lysis Buffer 3 with several 
gentle inversions; beads were re-pelleted using the magnet and the lysis buffer was 
aspirated. Beads were then re-suspended in 50 μl of Lysis Buffer 3 and returned to 
HulaMixer to rotate at 35 rpm overnight at 4°C. Beads were collected and washed 6 
times with 1 ml of the Lysis Buffer 3 and two times with 1 ml of the Wash Buffer 
(RIPA). All ChIP samples along with the 50 μl of the soluble chromatin were reverse-
crosslinked by adding 200 μl of the Elution buffer and 3 μl of 20 mg/ml Proteinase K 
(ThermoFisher Scientific, cat # AM2546) and incubated at 65°C for overnight. Beads 
were collected and the solutions were transferred into a new 1.5 microfuge tube 
containing 1 μl of 10 mg/ml RNase A (ThermoFisher Scientific, cat # EN0531) and left 
at room temperature for an hour. The ChIP and input DNA were purified using QIAquick 
PCR Purification Kit (QIAGEN, cat # 28104) and eluted in 50 μl of 50°C Nuclease-Free 
Water (Thermo Fisher Scientific, AM9932). The concentration and size distribution of 




were prepared using NEBNext Ultr II DNA Library Prep kit (NEB, E7645S) following 
the provider’s instruction manual. Amplified libraries were Bioanalyzed again to check 
the size selection efficiency and to define the concentrations of libraries before preparing 
the library pool involving the same molarity of each library and sequenced by Illumina 
HiSeq 4000. An additional biological replicate for IRF8 (and corresponding input DNA) 
was sequenced using the Illumina NextSeq 500. 
2.5.9 ChIP-seq analysis 
 ChIP-seq reads were aligned to the human reference genome (hg19) using 
Bowtie2 (Langmead and Salzberg, 2012). Aligned reads were filtered for high quality 
and uniquely mappable reads (MAPQ > 30) using samtools (Li et al., 2009). Peak calling 
for TFs was performed using MACS2 (Zhang et al., 2008) with relaxed parameters on 
single experiments (P-value < 0.01) and peaks were filtered using the irreproducible 
discovery rate (IDR < 0.05) across biological duplicates (Landt et al., 2012). Peak calling 
for histone marks was performed using MACS2 (Zhang et al., 2008) with relaxed 
parameters on single experiments (P-value < 0.01) and experiments were filtered 
requiring identification in both biological duplicates (i.e. IDR was not used for histone 
marks analysis). Peaks were further filtered if they occurred in the ENCODE consortium 
blacklisted regions. Peak intersections were computed using bedtools (Quinlan and Hall, 
2010) by first merging the peaks from all TF ChIP-seq experiments into continuous 
genomic loci and identifying which TF(s) contained a peak within this union set. Raw 





2.5.10 Motif discovery and scoring 
 De novo motifs within peak sets were discovered using HOMER (Heinz et al., 
2010) (parameters: -size given -noweight -nlen 0 -len 6,8,10,12,14,16 -S 5) and 
subsequently used for motif scoring across all peaks. We also performed de novo motif 
analysis using MEME (Bailey et al., 2009) (meme-chip parameters: -dna -meme-mod 
zoops) and found consistent motifs (Supplementary Fig. 2.1). Log-odds scoring 
thresholds determined by HOMER against a set of random background sequences were 
used as significance thresholds for motif scanning. Motif scans on individual peaks were 
performed using a custom R script that implements the same scoring scheme as HOMER 
and reports the maximum log-odds score in each peak (available on Github: 
https://github.com/david-bray/nextPBM-paper). Uniform background probability for each 
nucleotide (0.25) at each position was used for log-odds scoring. We chose a uniform 
base-frequency background model to be consistent with that used by the HOMER 
algorithm, and to better support our biophysical interpretation of the nextPBM data, that 
is based solely on the contribution of each base to binding affinity. Motif logos were 
generated using the ggseqlogo R package (Wagih, 2017). Motifs and thresholds used for 
ChIP-seq analysis and PBM microarray design are provided (Supplementary File 2 from 
Mohaghegh et al., 2019). 
2.5.11 PBM design 
 PBM experiments were performed using custom-designed microarrays (Agilent 
Technologies Inc. AMADID 085624 and 085106, 8 × 60K format). 2,615 PU.1 binding 




fragments and placed into a fixed position in the PBM probe sequence. For each unique 
probe sequence, 5 replicate probes were included in each orientation (10 probes per 
unique site). For select genomic seed sequences, 60 matching SNV probes were included 
to assay all SNVs at the 20 positions of the binding site (Fig. 2.2). All SNV sites were 
also included with 5 replicates and in each orientation (10 probes per unique SNV site). 
Probes for assaying binding site ablations and synthetic EICE sites were similarly 
included with 10 probes per unique DNA site. Selection of binding sites from ChIP-seq 
data – Binding sites were only included from PU.1 ChIP-seq peaks demonstrating high 
reproducibility across biological duplicates (IDR < 0.01), with the exception of probes 
included specifically to assay binding to single-replicate regions. PU.1 ChIP-seq sites 
were categorized based on their log-odds motif score, proximity to cofactors, and 
enhancer state. PU.1 binding sites were selected from the PU.1 ChIP-seq peaks 
containing exactly one significant PU.1 site (see 2.5.10 Motif discovery and analysis 
above). For the genomic loci in the ‘weak PU.1 motif’ category we identified no 
significant PU.1 site and, therefore, used the PU.1 site with maximum log-odds score 
(Fig. 2.5). EICE sites were selected from PU.1-IRF8 co-occupied regions containing 
exactly one EICE site (see 2.5.10 Motif discovery and analysis above). Co-occupancy 
PU.1 with cofactors (C/EBPα and/or IRF8) was determined if a highly reproducible 
ChIP-seq peak (IDR < 0.01) for each factor overlapped by at least one base. A PU.1 
ChIP-seq peak was annotated as ‘PU.1-alone’ if it was located greater than 200 bases 
away from the nearest cofactor ChIP-seq peak (in all experiments, including duplicates, 




annotated using histone modification ChIP-seq data from biological duplicates and 
publicly available mRNA-seq data for THP-1 monocytes (GEO accession GSM927668). 
PU.1 sites were annotated as active if they occurred within 200 bases of the nearest 
H3K4me1 and H3K27ac peaks, and if the nearest gene was located between 2–500kb 
away and expressed above the median RPKM value. PU.1 sites were annotated as primed 
if they occurred within 200 bases of the nearest H3K4me1 peak only, and if the nearest 
gene was located between 2–500kb away and expressed below the median RPKM value. 
A full list of DNA probes used, their corresponding probe category and additional 
annotation can be found in the supplemental data (Supplementary File 1 from 
Mohaghegh et al., 2019). 
2.5.12 NextPBM and PBM experiments and analysis 
 Microarray DNA double stranding and basic PBM protocols are as previously 
described (Berger and Bulyk, 2009; Andrilenas et al., 2015). All wash steps were carried 
out in coplin jars on an orbital shaker at 125 rpm. Double-stranded DNA microarrays 
were first pre-washed in PBS containing 0.01% Triton X-100 (5 min), rinsed in a PBS 
bath, and then blocked with 2% milk in PBS for 1 hour. Following the blocking step, 
arrays were washed in PBS containing 0.1% Tween-20 (5 min), then in PBS containing 
0.01% Triton X-100 (2 min), and finally briefly rinsed in a PBS bath. Protein binding – 
Arrays were then incubated with the protein sample (IVT protein or THP-1 nuclear 
lysate, details in Supplementary File 3 from Mohaghegh et al., 2019) for one hour in a 
binding reaction buffer containing: 2% milk (final concentration); 20 mM HEPES buffer, 




mg/mL salmon testes DNA (Sigma D7656). Primary antibody – After protein incubation, 
microarrays were washed with PBS containing 0.5% Tween-20 (3 min), then in PBS 
containing 0.01% Triton X-100 (2 min), followed by a brief PBS rinse. Microarrays were 
then incubated with 10 μg/mL of primary antibody (see Supplementary File 3 from 
Mohaghegh et al., 2019) in 2% milk in PBS (20 min). Secondary antibody - After 
primary antibody incubation, microarrays were washed with PBS containing 0.5% 
Tween-20 (3 min), then in PBS containing 0.01% Triton X-100 (2 min), followed by a 
brief PBS rinse. Microarrays were then incubated with 7.5 μg/mL of alexa488-conjugated 
secondary antibody or alexa647-conjugated secondary antibody (see Supplementary File 
3 from Mohaghegh et al., 2019) in 2% milk in PBS (20 min). Excess antibody was 
removed by washing with PBS containing 0.05% Tween-20 (3 min), then PBS (2 min). 
PBM data analysis - Microarrays were scanned with a GenePix 4400A scanner and 
fluorescence was quantified using GenePix Pro 7.2. Exported data were normalized using 
MicroArray LINEar Regression (Berger et al., 2006). Microarray probe sequences are 
provided (Supplementary File 1 from Mohaghegh et al., 2019). PBM data analysis and 
SNV approach for logo generation is as previously described (Andrilenas et al., 2018). 
Similarity between the DNA binding models generated using nextPBM and those from 
previously published studies was computed using the PWMSimilarity function from the 
TFBSTools R bioconductor package (Tan et al., 2016) (Supplementary Fig. 2.2). A 
threshold binding z-score of 2.0 (at the seed probe) was imposed to ensure accurate 
binding models. Processed PBM z-score data is available in the supplementary data 




deposited in the NCBI GEO database (Accession: GSE123946). Scatterplots and 
boxplots were generated using the ggplot2 R package (Wickham, 2016). Motif logos 
were generated using the ggseqlogo R package (Wagih, 2017). The significance of PU.1 
binding affinity and motif scores between groups was calculated using the two-sided 
Wilcoxon–Mann-Whitney test implemented in R. 
2.5.13 PU.1-IRF8 cooperativity score 
 PU.1-IRF8 cooperativity was scored by quantifying the deviation of the observed 
EICE z-scores from an extract experiment from the expected z-scores based on the IVT 
sample experiment. To define the expected EICE z-scores a second degree polynomial 
model was fit to the z-scores for the canonical PU.1 probes as follows: 
 𝑦1 = 𝛽0 + 𝛽1𝑥1 + 𝛽2𝑥1
2 + 𝜀1 
where y1 is the vector of PU.1 z-scores observed in the extract sample, x1 is the vector of 
PU.1 z-scores observed for the IVT sample, β0 ⁠, β1 and β2 are coefficients of the best-fit 
polynomial model and ε1 is the vector of error terms needed to equate y1 to the function 
of x1 ⁠. A polynomial model was used to fit the canonical PU.1 site z-scores in place of a 
linear model to allow for non-linearity due to PU.1 concentration differences between 
experiments. 
 The coefficients fit above are then used to compute the expected EICE z-scores 
for the extract experiment based on the IVT experiment z-scores: 
 𝑦2 = 𝛽0 + 𝛽1𝑥2 + 𝛽2𝑥2
2 + 𝜀2 
where y2 is the vector of PU.1 z-scores observed at EICE probes in the extract sample, x2 




needed to equate y2 to the function of x2 comprised of the coefficients fit using the 
canonical PU.1 probes. 









2.6 Supplementary Information 
 
 
Supplementary Figure 2.1: PU.1 de novo motifs obtained using HOMER and MEME 
HOMER and MEME (meme-chip) de novo motifs for PU.1 ChIP-seq peaks with cross-replicate 
IDR < 0.01 (top row) and IDR < 0.05 (bottom row). Pearson correlation summarizing the 







Supplementary Figure 2.2: Similarity between nextPBM binding models and existing 
database entries 
(A) Similarity between a representative PU.1 binding model obtained with nextPBM using the 
SNV probe approach (see 2.5 Materials and Methods) and PU.1 binding models obtained in 
previously published in vivo (ChIP-seq) and in vitro (SELEX) investigations (CIS-BP motifs). 
Similarity is measured using the maximum Pearson correlation computed between the nextPBM 
PWM and the database PWM. Label above the nextPBM binding model corresponds to the 
identifier of the ChIP-seq peak from which the PU.1 seed probe was selected (see Supplementary 
File 1 from Mohaghegh et al., 2019). (B) Similarity between an FLI1 binding model generated as 
in (A) and FLI1 binding models obtained in previous investigations. Similarity is computed as in 
(A). (C) Similarity between a representative PU.1 binding model using an EICE seed probe and 







Supplementary Figure 2.3: PU.1 and IRF8 binding models at canonical PU.1 seed probes 
Left: nextPBM PU.1 binding models obtained using binding of PU.1 to 8 canonical seed probes 
and each of the single nucleotide variants of the seed sequence. Label above the model 
corresponds to the identifier of the ChIP-seq peak from which the PU.1 seed probe was selected. 
The score shown to the top right of each model is the PU.1 binding z-score obtained at the seed 
probe. Low-scoring models (binding with z-score < 2.0), where PU.1 does not bind well to the 
seed probe are highlighted in red and the corresponding model is tinted red. The Δz-score values 




obtained using the same 8 canonical PU.1 seeds. Low-scoring models (also with z-score < 2.0), 







Supplementary Figure 2.4: PU.1 and IRF8 binding models at EICE seed probes 
Left: PU.1 binding models obtained using binding of PU.1 to 4 EICE seed probes and each of the 
SNV probes of the seed sequence. Labels and z-scores are shown as in Supplementary Figure 2.3. 
Identical z-score thresholds are used as in Supplementary Figure 2.3. Right: IRF8 binding models 






Supplementary Figure 2.5: Immune-depletion of IRF8 from nuclear extract 
Western blot comparing IRF8 protein levels in untreated nuclear extract (NE) to NE where IRF8 
has been immune-depleted (Imm. Depl.). CBP protein levels were used as a loading control. Each 
sample includes 60µg of total nuclear extract protein. The Western blot has been cropped for 






Supplementary Figure 2.6: Phosphatase assay validation 
Western blot comparing protein levels of phosphorylated RNA polymerase II (pPolII) in 
untreated nuclear extract to nuclear extract treated with broad-spectrum phosphatase. IRF8 
protein levels were used as a loading control. The Western blot has been cropped for clarity. 




CHAPTER THREE: CASCADE – Customizable high-throughput platform for 
profiling cofactor recruitment to DNA to characterize cis-regulatory elements and 
screen non-coding single-nucleotide polymorphisms 
Note: A substantial portion of this chapter is based on a pre-print manuscript uploaded to 
the biorXiv with David Bray (DB) and Heather Hook (HH) featured as co-first authors 
and equal contributors. The CASCADE hybrid experimental/computational technique 
was jointly conceived by DB, HH, and Trevor Siggers (TS). All the experimental work, 
including the CASCADE/nextPBM array experiments and validation, was performed by 
HH. nextPBM and CASCADE microarrays, analysis algorithms, and visualizations were 
designed and implemented by DB with input from TS. Individual author contributions to 
figures are noted in each respective figure legend. Supplementary data published 




 Determining how DNA variants affect the binding of regulatory complexes CREs 
and non-coding single-nucleotide polymorphisms (ncSNPs) is a challenge in genomics. 
To address this challenge, we have developed CASCADE (Comprehensive ASsessment 
of Complex Assembly at DNA Elements), which is a PBM-based approach that allows 
for the high-throughput profiling of COF recruitment to DNA sequence variants. The 
method also enables one to infer the identity of the TF-COF complexes involved in COF 
recruitment. We use CASCADE to characterize regulatory complexes binding to CREs 




macrophages. By profiling the recruitment of the acetyltransferase p300 and MLL 
methyltransferase component RBBP5, we identify key regulators of the chemokine 
CXCL10, and by profiling a set of five functionally diverse COFs we identify a 
prevalence of ETS sites mediating COF recruitment at SNP-QTLs in macrophages. Our 
results demonstrate that CASCADE is a customizable, high-throughput platform to link 
DNA variants with the biophysical complexes that mediate functions such as chromatin 
modification or remodeling in a cell state-specific manner. 
3.2 Introduction 
 Determining the impact of genetic variation on CREs, such as enhancers and 
promoters that control gene expression, remains a challenge in modern genomics. 
GWASs have identified thousands of SNPs associated with human diseases, but the 
causal variants and their biological effects remain largely unknown (Chen et al., 2016; 
Gallagher and Chen-Plotkin, 2018; Alasoo et al., 2018). Variants underlying disease risk 
often function by altering CRE function and gene expression. For example, >50% of 
causal SNPs for autoimmune diseases are ncSNPs mapping to immune gene enhancers 
(Farh et al., 2015). Therefore, a major challenge in understanding disease susceptibility is 
to determine how non-coding DNA variants disrupt CREs. A further challenge is that 
DNA variants, such as eQTLs, often have effects in a single cell type (Alasoo et al., 
2018) or stimulation condition (Schmiedel, et al., 2018; Fairfax et al., 2014). Such studies 
highlight the need for experimental approaches to characterize the impact and 





 Current high-throughput approaches to study the molecular mechanisms by which 
ncSNPs alter gene expression are based primarily on computational predictions of TF 
binding (Farh et al., 2015; Harley et al., 2018; Rojano et al., 2019) or on allelic imbalance 
in genomic assays of TF binding and chromatin state (Harley et al., 2018; Bailey et al., 
2015; Buchkovich et al., 2015; Kumasaka et al., 2016; Shi et al., 2016; Valouev et al., 
2008). However, these approaches have various limitations. Genomic assays based on 
allelic imbalance are impractical as a general approach to study candidate ncSNPs 
because each DNA variant must be present in the assayed cells and each experiment can 
examine only a single TF or chromatin feature. Computational approaches that use PWM 
models to assess the impact of ncSNPs on TF binding offer a parallelizable approach, but 
can predict altered TF binding for only a fraction of ncSNPs (Farh et al., 2015; Soccio et 
al., 2015). Additionally, PWM-based approaches do not account for changes in TF 
activity, such as TF nuclear localization or interactions with COFs, that occur in response 
to cell-state changes and are known to affect ncSNP function (Schmiedel et al., 2018; 
Fairfax et al., 2014). 
3.3 Results 
3.3.1 The CASCADE approach 
 To address these challenges in ncSNP annotation, we have developed 
CASCADE– a PBM-based high-throughput approach to profile the DNA binding of TF-
COF complexes from cell nuclear extracts. PBMs are double-stranded DNA microarrays 
that allow protein-DNA binding to be assayed to thousands of DNA sequences (Berger et 




(Mohaghegh et al., 2019) to study DNA binding of TFs present in nuclear extracts. 
However, TFs function by recruiting COFs, which subsequently alter gene expression 
through diverse mechanisms such as histone modification or chromatin remodeling (Fig. 
3.1a) (Kouzarides, 2007). To directly interrogate TF-COF complexes, in CASCADE we 
extend nextPBM to profile recruitment of COFs to DNA variants using nuclear extracts 
(Fig. 3.1b). As many COFs, such as the acetyltransferase EP300/CBP, interact broadly 
with multiple TFs (Vo and Goodman, 2001; Goodman and Smolik, 2000; Janknecht and 
Hunter, 1996), we can assay many TF-COF complexes in a parallel manner by profiling 
recruitment of a single COF, without requiring previous knowledge of the TFs involved. 
Critically, by assaying COF recruitment to SNVs of a DNA sequence, we can determine 
a COF recruitment motif whose specificity allows us to infer the identity of the TF (or TF 
family) by comparison against TF motif databases (Fig. 3.1b). Therefore, conceptually, 
by profiling the recruitment of a limited set of COFs we can characterize the DNA 
binding of a much larger set of TF-COF complexes. Here, we demonstrate that 
CASCADE can be used to profile the DNA-sequence dependence of TF-COF complex 
binding to CREs or ncSNPs in a cell-state specific manner (Fig. 3.1c), providing a high-
throughput approach to address the biophysical impact of non-coding DNA variants on 





Figure 3.1: CASCADE approach and applications 
(a) COFs affect transcription and chromatin state. (b) COF recruitment to DNA is assayed by 
nextPBM. COF recruitment is assayed to a ‘seed’ probe (e.g., genomic-derived TF binding site 
sequence) and all SV probes. COF recruitment to SV probes yields nucleotide preferences along 
DNA sequence. Preferences are transformed to COF recruitment motif (i.e., a logo). Motifs are 
matched to TF motif databases to infer TF identity. (c) Overview of CASCADE applications. 
CASCADE can be applied to CREs or reference (REF) / ncSNP pairs. For CREs, tiling probes 
are used to span the genomic region, and COF motifs for each tiling probe are integrated into a 
CRE-wide COF motif. For ncSNP/REF pairs, COF motifs are determined for both and compared. 
Contributions: CASCADE concept and workflow was conceived jointly by DB, HH, and TS. 
 
3.3.2 Application of CASCADE to characterize cis-regulatory elements 
 To demonstrate the use of CASCADE to characterize CREs, we profiled the 




gene CXCL10 in resting and LPS-stimulated human THP-1 macrophages. CXCL10 is 
important for mediating the inflammatory response by promoting activation and 
recruitment of several types of immune cells, such as monocytes. The expression of 
CXCL10 is often dysregulated in autoimmune diseases and has been implicated in cancer 
pathogenesis (Lee et al., 2009; Liu et al., 2011). In LPS-induced activation of CXCL10 in 
macrophages, three separate TF binding sites in the promoter are required for full 
activation, two NF-κB binding sites and an interferon-sensitive response element (ISRE) 
(Majumder et al., 1998; Ohmori and Hamilton, 1993) (Fig. 3.2a), providing a test case for 
our CASCADE approach. p300 is a broadly acting acetyltransferase that is recruited by 
diverse TFs, including both NF-κB and IRF3 that function at the CXCL10 promoter Vo 










(a) Schematic of LPS-inducible recruitment of p300 to CXCL10 promoter in macrophages. (b) 
CRE-wide p300 recruitment motif and TFs IRF3 and p65/RELA across CXCL10 promoter. 
Experiments using extracts from LPS-stimulated or untreated (UT) macrophages are indicated 
with colored bars. p300 motifs are shown for biological replicate experiments (Replicate 1 and 2). 
(c) Schematic of condition-independent recruitment of RBBP5 to CXCL10 promoter. (d) CRE-
wide motifs for COF RBBP5 and TF IRF2 across the CXCL10 promoter segment. Experimental 
conditions as in (b). Contributions: CASCADE experimental work was performed by HH. 
CASCADE array design, analysis, and visualization was developed and implemented by DB with 
input from TS. 
 
3.3.3 Characterization of the recruitment of COFs to the CXCL10 promoter 
 To query p300 recruitment across the CXCL10 promoter segment (166 bp), we 
assayed recruitment to 29 tiling probes (each 26 bp long) generated at 5 bp intervals 
across the target promoter region (Fig. 3.1c, see 3.5 Materials and Methods, 
Supplementary Data 1 from Bray et al., 2020). For each tiling probe on our microarray, 
we also included all SV probes to allow a COF recruitment motif to be determined every 
5 bp (Fig. 3.1c). A CRE-wide p300 recruitment motif was then generated for each 
experimental condition by integrating these individual motifs across their overlapping 
positions (Fig. 3.2b, tracks 1-4, see 3.5 Materials and Methods). 
 Our CRE-wide recruitment motif revealed p300 recruitment to the three 
previously characterized TF binding sites occurred in an LPS-inducible manner (Fig. 
3.2b, tracks 1-4). These results are consistent with previous studies that demonstrated the 
LPS-inducible binding of IRF3 and NF-κB to the CXCL10 promoter (Ohmori and 
Hamilton, 1993; Tamura et al., 2008; Medzhitov and Horng, 2009; Sakaguchi et al., 
2003; Hagemann et al., 2009). To infer the identity of the TFs involved, we compared the 
p300 recruitment motifs to a database of previously characterized TF binding motifs (see 




(Supplementary Fig. 3.1a, track 1, Supplementary Fig. 3.1b, track 2) with known LPS-
dependent activity (Smale, 2012; Medzhitov and Horng, 2009). To confirm the binding 
of NF-κB and IRF3 at these sites, we also performed CASCADE experiments directly for 
the TFs RELA (the p65 subunit of NF-κB) and IRF3, using antibodies against the TFs 
instead of p300. p65 bound specifically to the previously characterized NF-κB sites and 
exhibited the expected DNA binding site specificity (Fig. 3.2b, track 6, Supplementary 
Fig. 3.2, track 14). IRF3 bound specifically to the ISRE (Sakaguchi et al., 2003; Honda 
and Taniguchi, 2006) and weakly to the two NF-κB sites, which is consistent with the 
indirect tethering of IRF3 by NF-κB previously reported in LPS-stimulated macrophages 
(Fig. 3.2b, track 5) (Ogawa et al., 2005; Leung et al., 2004). Critically, the binding motifs 
determined for IRF3 (Fig. 3.2b, track 5) and p65 (Fig. 3.2b, track 6) agree strongly with 
those for p300 (Fig. 3.2b, tracks 1-2) demonstrating that COF recruitment motifs can 
accurately capture the binding motifs for the underlying TFs. 
 To determine whether additional COFs with different effector functions are also 
recruited to the CXCL10 promoter segment, we profiled the recruitment of RBBP5, a 
core subunit of the MLL histone lysine methyltransferase complex (Fig. 3.2c, 
Supplementary Data 1 from Bray et al., 2020). Unlike the LPS-inducible recruitment of 
p300, RBBP5 is constitutively recruited to the CXCL10 promoter sequences at 
comparable levels in the presence or absence of LPS (Fig. 3.2d, tracks 7-8). RBBP5 is 
recruited only to the ISRE element, and not the NF-κB sites, demonstrating a different 
recruitment preference than p300. However, as IRF3 binding to the ISRE is LPS-induced 




RBBP5 to this site is dependent on a different TF. Furthermore, the COF recruitment 
motifs for p300 and RBBP5 at the ISRE site exhibit clear differences in nucleotide 
preference (e.g., RBBP5 prefers a 5’-AAANCGAAA-3’ consensus whereas p300 prefers 
a 5’-GAACGGAAA-3’ consensus; Fig. 3.2b, tracks 1-2, Fig. 3.2d, tracks 7-8). 
Comparing the RBBP5 recruitment motifs against a TF motif database (see 3.5 Materials 
and Methods), we identified IRF2 as a high-scoring match (Supplementary Fig. 3.1c, 
track 7, Supplementary Fig. 3.1d, track 8). IRF2, and the related IRF8, are both 
constitutively expressed in THP-1 macrophages, which would support the LPS-
independent RBBP5 recruitment. CASCADE analysis of both IRF2 and IRF8 yielded 
CRE-wide motifs that closely matched those obtained for RBBP5 (Fig. 3.2d, tracks 9-10, 
Supplementary Fig. 3.2, tracks 11-12). These results show that applying CASCADE to 
different COFs can reveal TF-COF complexes with distinct compositions and DNA-
binding specificities.  
3.3.4 A two-step CASCADE-based approach to characterize ncSNPs 
 To investigate the extent to which ncSNPs function by perturbing TF-COF 
complex binding, we used nextPBM/CASCADE approaches to screen ncSNPs for altered 
COF recruitment. To increase the number of ncSNPs that we could screen, we developed 
a hierarchical two-step approach to identify and characterize SNPs that affect binding of 
TF-COF complexes (Fig. 3.3a). In step one, COF recruitment to pairs of reference and 
SNP alleles is screened in order to identify variants that lead to significant differential 
COF recruitment (Fig. 3.3, step 1). In step two, to infer the identity of the TFs involved at 




these significant loci (Fig. 3.3, step 2). The COF recruitment motifs generated for each 
SNP locus can then be compared to TF motif databases to infer the identity of the TF 









(a) Overview of 2-step, CASCADE-based approach to characterize 1,712 SNP-QTLs. (1) Step 1: 
screen for differential COF recruitment to SNP-QTL/REF probe pairs. Number of probe pairs in 
each QTL class for which significant COF recruitment was identified in at least one experiment. 
(2) Step 2: CASCADE-based motifs are generated for SNPs identified as significantly bound. 
COF motifs are compared against TF-motif databases to infer TF identity. (b) Comparison of 
p300 differential recruitment across biological replicates. Comparison of q-values for replicates is 
shown (left). Comparison of differential nextPBM z-scores for SNP/REF pairs against p-values 
(combined across probe orientations – see 3.5 Methods) is shown for replicate experiments 
(right). Dashed lines represent a -log10(q-value) of 1.3 (equivalent to q < 0.05). QTL class for 
each SNP is indicated. (c) Comparison of differential COF recruitment across biological 
replicates is shown for candidate COFs and the TF PU.1. Contributions: 2-step differential COF 
screen and CASCADE follow-up concept was conceived jointly by DB, HH, and TS. 
Experimental work was performed by HH. Design and analysis of the screening and CASCADE 
experiments was performed by DB with input from TS and HH. 
 
 We used this two-step approach to profile COF recruitment to 1,712 SNP-QTLs 
associated with gene expression (eQTLs) and chromatin accessibility (caQTLs) changes 
in myeloid cells (Alasoo et al., 2018; Schmiedel et al., 2018; Fairfax et al., 2014) (Fig. 
3.3a, Supplementary Data 2 from Bray et al., 2020). We performed our analysis with 
nuclear extracts from THP-1 macrophages stimulated with IFN-γ and LPS (see 3.5 
Materials and Methods). To assess the impact of SNPs on different cellular functions, we 
profiled recruitment of five COFs from different functional categories: p300, a histone 
acetyltransferase; SMARCA4/BRG1, a subunit of the SWI/SNF chromatin remodeling 
complex; TBL1XR1, a subunit of the nuclear receptor corepressor (NCoR) complex; 
RBBP5, a subunit of the MLL histone lysine methyltransferase complex; and GCN5, a 
histone acetyltransferase. In addition to these COFs, we screened for differential binding 
of the TF PU.1 due to its known role in establishing the myeloid enhancer landscape and 
the previously demonstrated prevalence of the PU.1 binding motif at macrophage SNP-




3.3.5 Screening known myeloid SNP-QTLs for differential COF recruitment 
 Our step-one screen identified 164 total SNP alleles that reproducibly altered the 
recruitment of at least one of the tested COFs (Fig. 3.3b, Fig. 3.3c), representing 9.6% of 
the sites examined. 
 With the exception of the GWAS caQTL category, comparable proportions of the 
SNP-QTL categories tested reproducibly altered COF recruitment: 136 basal eQTLs 
(9.4%), 7 caQTL-eQTLs (8.6%), 1 GWAS eQTL (7.1%) and 20 response eQTLs 
(12.5%). Profiling the TF PU.1, we also observed widespread differential PU.1 binding at 
95 SNP-QTLs (Fig. 3.3c) including 23 that coincided with the differential recruitment of 
at least one of the COFs screened. 
 By examining the direction of the differential recruitment, we identified SNPs that 
caused gain or loss of TF-COF binding (Fig. 3.3b, Supplementary Fig. 3.3). For example, 
our screen identified 63 SNP alleles that led to statistically significant gain of p300 
recruitment (Fig. 3.3b, rightmost two panels, positive Δz-score) and 35 SNP alleles that 
led to a significant loss relative to the reference allele (Fig. 3.3b, rightmost two panels, 
negative Δz-score). In total, across all COFs and TFs screened, we observed differential 
recruitment/binding at 243 of the 1,712 SNP-QTLs (14.2%) with 134 gains, 108 losses, 
and one SNP demonstrating both. Of note, for each SNP exhibiting significant 
reproducible differential recruitment of more than one COF (40 total), the direction of the 
effect, either gain or loss, was consistent across each COF. These results demonstrate that 
our nextPBM COF-based approach can be used to reproducibly screen broad classes of 




3.3.6 Inference of TF families underlying differential cofactor recruitment at ncSNPs 
 For step two of our SNP analysis we used CASCADE to determine COF 
recruitment motifs at select loci. These motifs allow us to infer the identity of the TFs 
mediating differential COF recruitment at each locus (Fig. 3.3a, step 2). We selected 158 
basal eQTLs, 8 caQTL-eQTLs, 1 GWAS caQTL, 1 GWAS eQTL, and 22 response 
eQTLs, as these loci showed significant differential recruitment of one or more of the 
regulators screened (see 3.5 Materials and Methods, Supplementary Data 3 from Bray et 
al., 2020). To determine our COF recruitment motifs, we profiled the base preferences of 
the local genomic region (26 bp) centered at each of these SNP-QTLs. Consistent with 
our observed differential PU.1 binding, the COF recruitment motifs for many loci 
matched ETS-type binding motifs (Fig. 3.4). COF motifs were also identified that 
matched TBX/KLF/EGR zinc finger motifs, IRF/STAT motifs, and two motifs that did 
not match a known TF motif even at a relaxed stringency threshold (Fig. 4.4, see 3.5 
Materials and Methods). Comparing the recruitment motifs generated at a given SNP 
locus, we found the motif base preferences and alignment were consistent across COF 
and PU.1 experiments, confirming a common underlying TF-COF complex. Examining 
SNPs specifically affecting ETS motifs, we found that SNPs can impact different 
positions along the ETS motif, including both the variable 5’ flanking region 
(rs11940944, rs72755909, rs2526718) and the core ETS 5’-GGAA-3’ element (rs873458, 
rs1250568). These results highlight that COF recruitment motifs can provide a means to 





Figure 3.4: CASCADE-determined motifs at SNP loci 
COF recruitment motifs for p300, SMARCA4, TBL1XR1, GCN5, and RBBP5 are shown for 10 
SNP-QTL loci. PU.1 binding motifs at each locus are also shown. Position of the SNP location 
within each motif is shown with a shaded rectangle. QTL type of each SNP is indicated (left-hand 
side, colored dots). Only sites that met an imposed seed z-score threshold were plotted (see 3.5 
Materials and Methods). Corresponding reference and SNP are shown beneath each rsID. (-) 
denotes a site plotted as its reverse complement relative to the reference strand. For these sites, 
the reference and SNP alleles are also indicated as their complementary nucleotides. 
Contributions: CASCADE experimental work was performed by HH. CASCADE analysis and 
motif similarity analysis was performed by DB. 
 
3.3.7 Comparison of TF binding models associated with site-specific COF recruitment 
preferences 
 We highlight two gain-of-recruitment SNP-eQTLs identified in our screen to 




Our analysis for rs11950944 (G/A), a basal SNP-eQTL in myeloid cells (Schmiedel et al., 
2018), found that p300 (z-score: 2.36), SMARCA4 (z-score: 2.99), and TBL1XR1 (z-
score: 2.61) are recruited to the SNP allele but are either not recruited or are below our 
detection threshold for the reference allele (p300: z-score: - 0.13, SMARCA4: z-score: -
0.38, TBL1XR1: z-score: 0.37) (Fig. 3.5a left, Supplementary Data 3 from Bray et al., 
2020). The COF recruitment motifs for all three COFs matched significantly with ETS-
factor motifs (Fig. 3.5a, right). Consistent with our motif-based inferences, the ETS 
factor PU.1 preferentially bound the SNP allele (z-score: 5.99) though it could also be 
detected at the reference allele (z-score: 4.04). These results suggest a model where the 
SNP allele enhances the DNA binding of an ETS-family TF, possibly PU.1, which leads 
to enhanced recruitment of these COFs (Fig. 3.5c). We note that enhanced binding of 
PU.1 at DNA variants in murine myeloid cells has been previously shown to correlate 
with increased local histone modifications characteristic of primed and active regulatory 





Figure 3.5: Constructing models with CASCADE for SNP-eQTLs 
(a) Left column: CASCADE-determined COF recruitment motifs for p300, SMARCA4, 
TBL1XR1, GCN5, and RBBP5 at the local genomic region surrounding rs11950944. PU.1 
binding motif is also shown. Right column: TF binding motif with the strongest association to 
each corresponding CASCADE COF recruitment motif. Statistical significance (p-value) for TF 
matching is shown below each TF motif (see 3.5 Materials and Methods). Position of the SNP 
location within each motif is shown in the shaded area. QTL type and inferred TF category are 
indicated by the same color scheme as in Fig. 3.4. (b) Same as in (a) but for the local genomic 
region surrounding rs10833823. Only sites that met an imposed z-score threshold were plotted 




recruitment changes at SNP-eQTL rs11950944. (b) Same as in (c) but for SNP-eQTL 
rs10833823. Contributions: CASCADE experimental work was performed by HH. CASCADE 
analysis and motif similarity analysis was performed by DB. DB, HH, and TS jointly interpreted 
the results to posit mechanistic models. 
 
 Our analysis for a second basal SNP-eQTL rs10833823 (A/G) in myeloid cells 
(Schmiedel et al., 2018) identified a different scenario in which the entire panel of COFs 
tested were recruited to the reference allele, but the SNP allele caused significantly higher 
recruitment for three of the COFs: TBL1XR1 (z-scores: WT = 9.71, SNP = 28.49), 
GCN5 (z-scores: WT = 1.54 to SNP = 3.36), and RBBP5 (z-scores: WT = 10.56 to SNP 
= 15.82) (Fig. 3.5b left, Supplementary Data 3 from Bray et al., 2020). The COF 
recruitment motifs for all COFs matched GA-rich IRF/STAT-family motifs (Fig. 3.5b, 
right), and consistent with our inference of recruitment by IRF/STAT-type TFs, we did 
not observe PU.1 binding at this site (Fig. 3.5b, left). Notably, while the variant G allele 
enhanced COF recruitment in our assay, it occurred at a low-information position in the 
IRF/STAT binding motifs that did not appreciably affect the PWM scores for these TFs 
(Fig. 3.5b, left, highlighted position; Fig. 3.5b, right). The PWM binding models for 
several inferred TFs (Fig. 3.5b, right, IRF1, IRF4, STAT2) thereby predict that the 
variant position (Fig. 3.5b, left, highlighted position) does not affect TF binding but can 
alter the recruitment of several COFs (Fig. 3.5d) possibly by a mechanism involving 
DNA-based allostery (Meijsing et al., 2009; Gronemeyer and Bourguet, 2009). The 
functional consequences of this variant on COF recruitment would thereby not be 
captured by traditional computational annotation techniques based on PWM motif 




Touzet and Varre, 2007; Claeys et al., 2012; reviewed in Gan et al., 2018). It is also 
possible that binding of these TFs (e.g. IRF1, IRF4, and STAT2) is optimized by the 
variant G at that specific binding site (flanking rs10833823) which highlights an 
advantage of generating site-specific recruitment and binding models compared to PWMs 
that are constructed by aggregating information across many binding sites and genomic 
contexts. These results demonstrate how the CASCADE approach, based on site-specific 
COF-recruitment profiling, can generate biophysical, mechanistic models for how 
ncSNPs can alter the binding of TF-based regulatory complexes. 
3.4 Discussion 
 Characterizing the effects of DNA variants, such as ncSNPs, on gene regulatory 
complexes is a challenge in our efforts to explain the genetic contributions to human 
disease. A bottleneck in the field is that studies identifying the mechanisms by which 
ncSNPs function greatly lag studies identifying ncSNPs associated with traits or diseases 
(Gallagher and Chen-Plotkin, 2018). To address this need for high-throughput approaches 
to characterize ncSNPs, we developed CASCADE as a high-throughput, customizable 
platform for profiling the impact of DNA variants on TF-COF complexes. By measuring 
the DNA recruitment of broadly interacting COFs (i.e., that form complexes with many 
TFs), this approach can assay multiple TF-COF complexes in a multiplexed manner. 
Furthermore, as CASCADE queries the binding of TF-COF complexes, as opposed to 
just TFs, it can suggest a link between DNA variants and the biological functions 
mediated by each COF. In this work, we have applied CASCADE to the study of 




such as rare variants associated with disease or somatic mutations associated with cancer. 
We envision that using CASCADE in conjunction with other high-throughput, cell-based 
methods, such as MPRAs that assess gene expression (Melnikov et al., 2012; Tewhey et 
al., 2016; Ernst et al., 2016) will provide exciting new approaches to characterize 
function and mechanism of DNA variants at a genomic scale. 
 As disease-associated ncSNPs often reside within CREs (Alasoo et al., 2018; Farh 
et al., 2015; Fairfax et al., 2014; Maurano et al., 2012) the characterization of ncSNPs is 
directly related to the problem of delineating the mechanisms of CREs. Here, we 
demonstrate that CASCADE can be applied to this fundamental problem and can be used 
to identify TF binding sites within CREs and the TF-COF complexes that bind to these 
sites under different cellular conditions. Using CASCADE to characterize an LPS-
inducible segment of the CXCL10 promoter, we identified the three previously validated 
NF-κB and IRF sites involved and TF-COF complexes bound to each individual site. In 
this work, we profiled a limited set of COFs, but the approach can be applied to other 
COFs where native antibodies are available, or COFs have been affinity tagged. We also 
demonstrated that we can identify site-specific recruitment of COFs that are annotated as 
subunits of larger, multi-protein COF complexes (e.g., RBBP5, Fig. 3.2c). Currently it is 
unclear the extent to which these multi-protein COF complexes are assembled on our 
microarrays, or whether we are assaying the recruitment of smaller sub-complexes or 
even single COFs (i.e., binary TF-COF interactions). Future studies will address the 
extent to which recruitment of larger COF complexes is being assayed and how 




in vivo. Finally, we note that CASCADE provides the first, high-throughput approach to 
establish the link between individual CRE binding sites, TFs, and COFs. We anticipate 
that CASCADE will allow for renewed examination of the role COFs play in the cis-
regulatory logic that governs CRE function, which has primarily focused on TFs and 
binding sites alone. 
 We recognize that there are technical limitations to the CASCADE approach in 
the detection of differential COF recruitment events and the motif-based analyses used to 
infer TFs underlying these differential COF recruitment sites. The paired 
reference/alternate allele screening procedure successfully identified differential COF 
recruitment sites that, when profiled using the full CASCADE procedure, demonstrated 
COF recruitment preferences consistent with previous TF binding models. Although, we 
acknowledge that agreement across technical replicates of the screening procedure was 
generally poor in particular when profiling COF recruitment (Fig. 3.3b, Fig 3.3c). We 
therefore selected only the sites that demonstrated reproducible COF recruitment 
differences for downstream analyses (see 3.5 Materials and Methods). Furthermore, 
motif-based inferences identifying TFs underlying differential COF recruitment events 
could largely only be resolved at the TF family-level (e.g. IRF or ETS). COF recruitment 
and TF binding motifs, such as those involving IRF3 at the CXCL10 promoter, 
demonstrated consistent nucleotide preference differences (Fig. 3.2b, tracks 1 and 5) that 
differed relative to the reference IRF3 binding model (Supplementary Fig. 3.1). Though 
these may indicate some influence of the p300 cofactor on altering the binding preference 




are required by IRF3 to bind to the CXCL10 promoter in a site-specific manner that is not 
captured by a PWM (or similar binding model) that aggregates nucleotide preference 
information over many binding sites. Furthermore, PWMs for related TFs, such as the 
IRFs, can closely resemble one another and ignore additional biological contexts such as 
the cell state-specific activation or upregulation of signal-dependent TFs as well as their 
potential dimerization partners. For these reasons, associating a site-specific COF 
recruitment or TF binding model with a specific member of a TF family based on motifs 
alone remains difficult. In this study, we integrated the motif-level inferences with 
additional biological insight, such as the known LPS-inducibility of IRF3, to support our 
predictions. Exploring methods to address these limitations and improve the detection of 
differential COF recruitment and inference of underlying TFs will be the focus of future 
investigations. For example, our group has begun exploring alternate screening 
procedures that include additional replicate probes and allow for differential COF 
recruitment to be computed across several adjacent sites that we expect will result in 
more robust detection of differential COF recruitment based on our preliminary 
experiments (discussed later in Chapter 5, section 5.4). In addition, more objective and 
quantitative methods to integrate motif-level information with additional biological 
context, such as expression or activity levels of a TF within the condition being profiled, 
will be explored in order to improve the inference of TFs underlying observed COF 
recruitment sites. 
 The CASCADE approach introduced here is a scalable, customizable platform to 




complexes. In this study, we demonstrate its application to the functional characterization 
of CREs and ncSNPs. However, it can be customized and applied to many other types of 
DNA variants and elements in a cell-specific manner, such as mutations in different 
cancers or synthetic regulatory elements designed to drive a cell-specific response. We 
show the application of CASCADE to nuclear extracts from a human macrophage cell 
line, but conceptually the approach can be used with nuclear extracts from any cell or 
tissue type. Finally, the ability to profile COF recruitment to DNA sites provides an 
opportunity to link DNA variants with therapeutic intervention. COFs are often 
enzymatic (e.g., methyltransferases, histone deacetylases, etc.) and therapeutic inhibitors 
for many COFs are available (Altucci and Rots, 2016; Cortez and Jones, 2008). 
Identifying the TF-COF complexes whose binding site is created by a DNA variant may 
allow for the identification of therapeutic antagonists to counteract their effects. Future 
studies applying CASCADE in these diverse scenarios should help to develop the 
approach and provide insights into the roles of TF-COF complexes in cell signaling and 
disease. 
3.5 Materials and Methods 
3.5.1 Cell culture 
 THP-1 cells, a human monocyte cell line, were obtained from ATCC (TIB-202). 
The cells were grown in suspension in RPMI 1640 Glutamax media (Thermofisher 
Scientific, Catalogue #72400120) with 10% heat-inactivated FBS (Thermofisher 
Scientific, Catalogue #11360070) and 1mM sodium pyruvate (Thermofisher Scientific, 




flasks were used when culturing THP-1 cells for experiments. Cells were grown in 50mL 
of media when being cultured in T175 flasks. 
 To differentiate THP-1 cells into adherent macrophages, cells were grown to a 
density of 8.0 × 105 cells/mL and treated with 25ng/mL Phorbol 12-Myristate 13-Acetate 
(PMA) (Sigma-Aldrich, Catalogue #P8139) for 4 days. Following the 4 days of PMA 
treatment, the media was replaced with fresh RPMI media with 10% heat-inactivated 
FBS and 1mM sodium pyruvate. The cells rested for two days in the fresh media before 
being stimulated with various reagents. 
 THP-1 cells differentiated with PMA were treated with either LPS (Sigma-
Aldrich, L3024) or interferon gamma (IFN-γ) (Thermofisher Scientific, Catalogue 
#PHC4031) in combination with LPS. PMA treated THP-1 cells were treated with 
1ug/mL of LPS for 45 min or with 100ng/mL IFN-γ for 2 h followed by 1ug/mL LPS for 
1 h. For each condition, nuclear lysates were harvested. For all nuclear lysates assayed 
using PBM experiments, the expression levels of COFs and TFs profiled with 
CASCADE were confirmed by western blotting (Supplementary Fig. 3.4). 
3.5.2 nextPBM experimental methods 
 The nuclear extract protocols are as previously described (Mohaghegh et al., 
2019). Changes to the previously published protocols are detailed. To harvest nuclear 
extracts from THP-1 cells, the media was aspirated off and the cells were washed once 
with 1X PBS (Thermofisher Scientific, cat #100010049). Once the 1X PBS used to wash 
the cells was aspirated off, enough 1X PBS was mixed with 0.1mM Protease Inhibitor 




was then used to dislodge the cells from the flask. The cells were collected in a Falcon 
tube and placed on ice. To pellet the cells, the cell volume was centrifuged at 500xg for 5 
min at 4°C. Once the cells were pelleted, the supernatant was aspirated off. The pellet 
was resuspended in Buffer A and incubated for 10 min on ice (10mM HEPES, pH 7.9, 
1.5mM MgCl, 10mM KCl, 0.1mM Protease Inhibitor, Phosphatase Inhibitor (Santa-Cruz 
Biotechnology, Catalogue #sc-45044), 0.5mM DTT (Sigma-Aldrich, Catalogue #4315)) 
to lyse the plasma membrane. After the 10 min incubation, a final concentration of 0.1% 
Igepal detergent was added to the cell and Buffer A mixture and vortexed for 10 sec. To 
separate the cytosolic fraction from the isolated nuclei, the sample was centrifuged at 
500xg for 5 min at 4°C. The cytosolic fraction was collected into a separate 
microcentrifuge tube. The pelleted nuclei were then resuspended in Buffer C (20mM 
HEPES, pH 7.9, 25% glycerol, 1.5mM MgCl, 0.2mM EDTA, 0.1mM Protease Inhibitor, 
Phosphatase Inhibitor, 0.5mM DTT, and 420mM NaCl) and then vortexed for 30 sec. 
The nuclei were incubated in Buffer C while mixing at 4°C. To separate the nuclear 
extract from the nuclear debris, the mixture was centrifuged at 21,000xg for 20 min at 
4°C. The nuclear extract was collected in a separate microcentrifuge tube and flash frozen 
using liquid nitrogen. Nuclear extracts were stored at -80°C until used for experiments. 
 Microarray DNA double stranding and PBM protocols are as previously described 
(Berger et al., 2006; Berger and Bulyk, 2009; Mohaghegh et al., 2019). Any changes to 
the previously published protocols are detailed. Double-stranded microarrays were pre-
wetted in HBS (20mM HEPES, 150mM NaCl) containing 0.01% Triton X-100 for 5 min 




1 h in the dark in a binding reaction buffer (20mM HEPES, pH 7.9, 100mM NaCl, 1mM 
DTT, 0.2mg/mL BSA, 0.02% Triton X-100, 0.4mg/mL salmon testes DNA (Sigma-
Aldrich, cat #D7656)). The array was then rinsed in an HBS bath containing 0.1% 
Tween-20 and subsequently de-wetted in an HBS bath. After the protein incubation, the 
array was incubated for 20 min in the dark with 20ug/mL primary antibody for the TF or 
COF of interest (Supplementary Table 3.1). The primary antibody was diluted in 2% milk 
in HBS. After the primary antibody incubation, the array was first rinsed in an HBS bath 
containing 0.1% Tween-20 and then de-wetted in an HBS bath. Microarrays were then 
incubated with 10ug/mL of either alexa488 or alexa647 conjugated secondary antibody 
(Supplementary Table 3.1) for 20 min in the dark. The secondary antibody was diluted in 
2% milk in HBS. Excess antibody was removed by washing the array twice for 3 min in 
0.05% Tween-20 in HBS and once for 2 min in HBS in coplin jars as described above. 
After the washes, the array was de-wetted in an HBS bath. Microarrays were scanned 
with a GenePix 4400A scanner and fluorescence was quantified using GenePix Pro 7.2. 
Exported fluorescence data were normalized with MicroArray LINEar Regression 
(Berger et al., 2006). 
3.5.3 CASCADE microarray designs and analyses 
 A known LPS-responsive segment of the CXCL10 promoter (hg38: chr4) from 
76023583 to 76023748 was used for the basis of this array design (Majumder et al., 
1998). The genomic region was tiled through using 26-base “target” probe sequences 
with a 5-base step forward between sequential tiles. In total, 29 of these tile probes were 




corresponding to the genomic locus were obtained from the hg38 genome fasta file 
included with Bowtie2 (Langmead and Salzberg, 2012) using the “fastaFromBed” 
function from bedtools v2.26.0 (Quinlan and Hall, 2010). For each tile probe and each 
position along the corresponding 26-base target region, a probe was included in the array 
design consisting of each possible nucleotide variant (at that position) in order to employ 
the variant probe analysis approach (see below). A total of 2,291 targets were therefore 
used to model the CXCL10 promoter segment (29 tiles + 29 × 3 variant probes x 26 
positions). 500 additional 26-base target regions were randomly selected from the hg38 
using the bedtools “shuffleBed” function and included in the array design to build a 
background distribution of fluorescence intensity. Each 26-base target region in the array 
design was embedded in a larger 60-base PBM probe as follows: 
 
“GCCTAG” 5’ flank – 26-base target region – “CTAG” 3’ flank – 
“GTCTTGATTCGCTTGACGCTGCTG” double-stranding primer 
 
 Each target region was included in its reference (+) orientation as well as the 
reverse complement (-) orientation. 5 replicate spots of each probe (in each orientation) 
were included in the final array design. PBM microarray probes, relevant annotation for 
each, and the experimental results are provided (Supplementary Data 1 from Bray et al., 
2020). The microarrays were purchased from Agilent Technologies Inc. (AMAID: 




 To design the nextPBM-based screen for differential COF recruitment at ncSNPs, 
the lead SNPs uncovered in previous studies were included in our high-throughput screen 
as follows: 1,446 basal eQTLs (Schmiedel et al., 2018) (randomly selected from the 
“classical monocytes” category), 81 caQTL-eQTLs, 11 GWAS caQTLs, 14 GWAS 
eQTLs, and 160 response eQTLs (Alasoo et al., 2018). Chromosomal coordinates (hg38) 
for each SNP were obtained using the biomaRt R package from Ensembl (Durinck et al., 
2009). 26-base DNA probe target regions centered at the SNP position (relative to + 
strand: 13 bases + SNP location + 12 bases) were obtained for each reference (REF) 
allele using bedtools as above. For each REF allele probe, a probe with the corresponding 
SNP allele was also included in the design such that each rsID is represented by a pair of 
REF and SNP probes. 500 background target regions were also included using the same 
procedure as above. The 26-base target regions were embedded in larger 60-base PBM 
DNA probes as above. 5 replicates of each probe (in both orientations) were included in 
the final design. The microarrays were purchased from Agilent Technologies Inc. 
(AMAID: 085920, format: 8×60K). 
 Each REF/SNP pair was screened for differential recruitment of p300, 
SMARCA4, TBL1XR1, RBBP5, and GCN5 as well as differential binding of 
representative ETS factor PU.1 nextPBM experimental results were preprocessed as 
above. Z-scores were obtained for each probe as previously described (Andrilenas et al., 
2018) against the distribution of fluorescence intensities obtained at the set of background 
probes for a given experiment. For each REF and SNP allele pair in the design, a t-test 




and 5 SNP probes for a given COF/TF assayed. To mitigate the influence of probe 
orientation-specific effects, t-tests were performed independently for each probe 
orientation with the p-values combined using Fisher’s method. The Benjamini-Hochberg 
method was used to adjust the individual p-values for a REF/SNP pair for multiple 
hypothesis testing. The fluorescence intensity z-score difference for a given REF and 
SNP allele probe pair (termed Δz-score) was computed by subtracting the mean REF z-
score from the mean SNP z-score such that a positive Δz-score represents a gain-of-
recruitment introduced by the SNP allele and a negative Δz-score represents a loss. 
Scatterplots based on the screening results (Fig. 3.3b-c) were plotted using the ggplot2 
(Wickham, 2016), RColorBrewer (Neuwirth, 2014), and cowplot (Wilke, 2019) R 
packages. A full data file including the statistics from the high-throughput differential 
recruitment screen is included in the supplementary materials (Supplementary Data 2 
from Bray et al., 2020). 
 Reference and SNP allele pairs exhibiting reproducible significant differential 
COF recruitment and/or TF binding were selected for this CASCADE array design in 
order to infer regulators responsible for the differential activity observed. Inclusion 
criteria was as follows: the difference in recruitment (or binding) of a given COF (or TF) 
between corresponding REF and SNP allele probes must have obtained an adjusted p-
value (q-value) < 0.05 independently in both technical replicates with a concordant 
direction of effect. Single variant probes for the 26-base target regions (centered at the 
SNP position – as described above) were generated using the same procedure as above 




segment used previously. In addition, only 291 background probes were included due to 
probe number limitations. PBM microarray probes, relevant annotation for each probe, 
and the experimental results are provided (Supplementary Data 3 from Bray et al., 2020). 
The microarrays were purchased from Agilent Technologies Inc. (AMAID: 086248, 
format: 4×180K). 
 Motif modeling using SV probes was performed as previously described 
(Mohaghegh et al., 2019; Andrilenas et al., 2018; Penvose et al., 2019) for the SNP-QTL 
sites profiled in detail using CASCADE. For the multi-tile design used to model extended 
loci such as the LPS-responsive CXCL10 promoter segment, a weighted mean approach 
was applied as follows to overlapping positions in order to integrate results across 
sequential tiles: all variant probes corresponding to a given nucleotide at a given position 
within the promoter segment were averaged using each probe’s corresponding seed 
(reference genomic) z-score as a weight. Further, if a given SV probe’s z-score was 
above 1.645 (above approximately 95% of the fluorescence intensities obtained using 
background probe distribution - assuming a normal distribution) and the SV probe’s 
corresponding reference probe z-score was less than or equal to 1.645, the SV probe’s z-
score was reset to the reference seed value. This procedure ensured that the SV probe 
modeling approach was used to characterize true genomic recruitment sites and reduce 
the influence of COF recruitment sites gained specifically via a non-reference (non-
genomic) variant. Sequence logo plots for the COF recruitment and TF binding motifs 
were generated using the ggseqlogo R package (Wagih, 2017) and arranged using 




to the median z-score obtained across all possible nucleotides at that position and was 
computed after the weighted averaging procedure described previously. The Δz-score 
axis limits for the logo tracks (Fig. 3.2, Supplementary Fig. 3.2) were determined using 
the minimum and maximum Δz-scores obtained for a given COF/TF (across experiments 
within an array design) to enable comparisons across stimulus conditions assuming 
matched total protein concentrations across experiments. 
3.5.4 Motif similarity analysis 
 For CASCADE recruitment motifs obtained at the CXCL10 locus, to simplify the 
analysis and reduce the number of comparisons, the promoter segment was first separated 
into 3 motifs broadly corresponding to each previously characterized TF site (ISRE, NF-
κB-2, and NF-κB-1). For CASCADE profiling of the SNP-QTLs, a minimal seed z-score 
of 1.5 was enforced for motif analysis. Recruitment energy matrices obtained from 
CASCADE cofactor profiling (fluorescence intensity z-scores) were converted to a 
probability-based matrix using the Boltzmann distribution as previously described 
(Andrilenas et al., 2018) to be more directly comparable to previous TF binding models: 
 
 zik is the z-score for nucleotide variant k at position i within the motif window. β 
transformation parameters for the Boltzmann equation were scaled using the maximum z-
score obtained in a given experiment using the following equation in order to account for 





 Resulting position-weight matrices were compared against the complete 
HOCOMOCOv11 database (Kulakovskiy et al., 2018) of TF binding models (771 total) 
using TOMTOM from the MEME suite (Gupta et al, 2007) version 5.0.3. Euclidean 
distance was used as the similarity metric with a relaxed minimal reporting q-value of 
0.25 (-dist ed -thresh .25). 
3.5.5 Data availability 
The results of all nextPBM/CASCADE array experiments performed here have 
been deposited in the Gene Expression Omnibus (GEO accession: GSE148945). An R 
script that implements CASCADE to generate the plots shown in this study using the 
Supplementary Data files has been made available on Github (https://github.com/Siggers-




3.6 Supplementary Information 
Antibody Catalog Number Application 
Primary Antibodies 
P300 ab14984 PBM Experiment/Western 
Blot 
SMARCA4 sc17796 PBM Experiment/Western 
Blot 
GCN5 sc-365321x PBM Experiment/Western 
Blot 
RBBP5 a300-109A PBM Experiment/Western 
Blot 
TBLX1R1 sc-100908 PBM Experiment 
HDAC1 ab7028 PBM Experiment 
P65 sc-372X PBM Experiment 
P65 sc-8008 Western Blot 
IRF8 sc-6058X PBM Experiment 
IRF3 D83B9 PBM Experiment 
IRF2 sc-374327 PBM Experiment 





Donkey anti-goat IgG (H+L) 
Cross-Adsorbed Secondary 
Antibody, Alexa Fluor 488 
A11055 PBM Experiment 
Goat anti-mouse IgG (H+L) 
Highly Cross-Adsorbed 
Secondary Antibody, Alexa 
Fluor 488 
A11029 PBM Experiment 
Goat anti-rabbit IgG (H+L) 
Highly Cross-Adsorbed 
Secondary Antibody, Alexa 
Fluor 488 
A11034 PBM Experiment 
Goat anti-mouse IgG (H+L) 
Highly Cross-Adsorbed 
Secondary Antibody, Alexa 
Fluor 647 
A32728 PBM Experiment 
Goat anti-rabbit IgG (H+L) 
Highly Cross-Adsorbed 
Secondary Antibody, Alexa 
Fluor 647 
A32733 PBM Experiment 
HRP conjugated Goat anti-
mouse 
G-21234 Western Blot 
HRP conjugated Goat anti-
rabbit 
G-21040 Western Blot 
Supplementary Table 3.1: Antibodies used for experiments 






Supplementary Figure 3.1: Model-based inference of transcription factors associated with 
CXCL10 promoter COF recruitment motifs 
(a) TF motifs matched to p300 recruitment preferences in LPS-stimulated macrophages 
(Replicate 1). (b) TF motifs matched to p300 recruitment preferences in LPS-stimulated 
macrophages (Replicate 2). (c) TF motif matched to RBBP5 recruitment preferences in LPS-
stimulated macrophages (d) TF motif matched to RBBP5 recruitment preferences in untreated 
macrophages. All COF recruitment preference tracks were converted to probability-based models 




binding models was performed using TOMTOM and the full HOCOMOCOv11 motif database 






Supplementary Figure 3.2: Additional CASCADE-based analyses of TF binding to the 
CXCL10 promoter segment 
Nucleotide binding preferences of IRF8 to the CXCL10 promoter segment in paired LPS-
stimulated (track 11 - continued from Fig. 3.2) and untreated (track 12) macrophages. Binding 









Supplementary Figure 3.3: Statistical significance and direction-of-effect for changes in 
COF recruitment and TF binding across reference and SNP probe pairs screened 
Rows represent volcano plots obtained for different COFs (SMARCA, TBL1XR1, RBBP5, 
GCN5) and TF PU.1. Left column shows the volcano plots obtained in a first replicate and right 
column shows the volcano plots obtained in a technical replicate experiment. Statistical 
significance threshold for each experiment (q < 0.05, see 3.5 Materials and Methods) is shown as 






Supplementary Figure 3.4: Western blot of PMA-treated THP-1 NEs 
The protein expression levels of p300, SMARCA4, GCN5, RBBP5, and p65 of PMA treated 
THP-1 cells were evaluated by western blotting. 30ug of nuclear extract were loaded for all 
samples. PMA treated THP-1 cells were treated with LPS for 45 min to induce p65 expression. 
PMA treated THP-1 cells were treated with IFNγ for 3 h to prime the immune response. PMA 
treated THP-1 cells were treated with IFNγ for 1 h and LPS were treated with IFNγ for 2 h 
followed by LPS stimulation for 45 min. Ponceau S staining was used as a loading control. 




CHAPTER FOUR: The human TF array – surveying cofactor recruitment to the 
binding sites of human transcription factors 
Note: The human transcription factor (hTF) microarray design idea was jointly conceived 
by David Bray (DB), Heather Hook (HH), Rose Zhao (RZ) and Trevor Siggers (TS) 
based on a pilot series of microarray designs and analyses by RZ and Jessica Keenan 
(JK). All pilot experimental work on the immune TF-centric coregulator recruitment 
(CoRec) array series of experiments prior to the development of the hTF array was 
performed by RZ and JK with input from TS. The pilot experimental work on the hTF 
microarray design was performed by RZ with input from HH and TS. The specific hTF 
array design, software used to design the array, and interactive array analysis and 
visualization software were designed and implemented by DB with input from HH, RZ, 
and TS. Individual author contributions to figures are noted in each respective figure 
legend.  
4.1 Abstract 
 COFs recruited to TF binding sites (TFBSs) are the effectors of gene regulatory 
activities such as histone modification and chromatin remodeling. Despite the importance 
of TF-COF complex assembly on the activity of a TF, existing assays to measure TF 
activity have focused traditionally only on TF binding or on the presence/translocation of 
TFs into the nucleus. We propose that a more functionally relevant assessment of TF 
activity is to identify TF-COF complexes present in the cell nucleus and capable of 
binding to DNA. As a general framework to map such TF-COF complexes in cells, we 




expansive panel of 346 non-redundant consensus TFBSs and their SNVs. This array 
design (the human TF – or hTF array) allows users to examine the activity of a wide 
panel of human TFs by profiling TF-COF complexes in any cell type or condition. To 
facilitate the application of this experimental approach, we have developed an analysis 
suite to allow users to explore COF recruitment results obtained using the hTF 
microarray. In pilot experiments exploring LPS-dependent coactivator and corepressor 
recruitment to the hTF panel, we use our analysis software to generate condition-specific 
COF recruitment comparisons at the DNA probe-level, visualize the sequence 
determinants of COF recruitment at the TF-level, and delineate condition-specific TF-
COF complex “signatures” across all TFs included in our panel. We anticipate that the 
hTF platform and the concept of TF-COF recruitment signatures will provide a valuable 
annotation layer to refine our understanding of cell- and state-specific gene regulatory 
logic. 
4.2 Introduction 
 COFs present at CREs such as promoters and enhancers are key effectors in gene 
regulation. Individual COFs and multi-protein COF complexes recruited to DNA by 
sequence-specific TFs have diverse roles in histone modification, chromatin remodeling, 
and assembling the transcription preinitiation complex through their enzymatic activities 
(Kouzarides, 2007; Vo and Goodman, 2001). As COF recruitment to cell type- or 
context-dependent CREs can depend on the expression, nuclear localization, and PTMs 
of signal-dependent TFs (Zabidi and Stark, 2016; Haberle and Stark, 2018; Reiter et al., 




which TF-COF complexes are capable of assembling at CREs under diverse cellular 
conditions. 
 To address important limitations to existing methods to profile the assembly of 
TF-COF complexes at DNA, our group recently developed the CoRec (Cofactor 
Recruitment) method (Keenan, 2019). CoRec is an HT extension to our PBM-based COF 
recruitment approaches such as CASCADE (Bray et al., 2020). Prior to CoRec, assays to 
investigate the TFs active in a given cellular context have been limited to TF activation 
profiling arrays that assay the presence of up to hundreds of TFs in cell nuclei (Luminex 
200 from Active Motif; Zhou et al., 2017; Ding et al., 2013). Unlike CoRec, these 
methods do not explicitly interrogate TF-COF complexes nor do they quantify the effects 
of DNA variants on the binding of these complexes. Methods such as M2H allow for the 
characterization of binary interactions between proteins but do not capture specific 
differences attributable to different cell-specific conditions (Riegel et al., 2017). 
Moreover, cell-based HT methods such as COF ChIP-seq provide stimulus-specific 
genome-wide maps of COF locations (Raisner et al., 2018; Blow et al., 2010; Ramos et 
al., 2010)  but the peaks can span hundreds of bases and multiple TF binding motifs 
making it difficult to infer causality between TF binding and TF-COF complex assembly. 
Furthermore, it is difficult to manipulate the cellular and genomic context, as in assays 
such as ChIP-seq, to further probe the sequence- or context-dependent determinants of 
COF recruitment and TF-COF complex assembly beyond the nucleotides occurring 




 To address the aforementioned limitations of these assays, the CoRec approach 
was developed as an HT cell-based method to survey recruitment of a COF of interest to 
a panel of known TFBSs in a given cellular context. To demonstrate the utility of the 
method we profiled the recruitment of a diverse set of COFs (including coactivators, 
corepressor subunits, chromatin remodeling enzyme subunits, and more) to a panel of 91 
known immune-centric TFBSs in different immune cell contexts (Keenan, 2019). By 
comparing the TF-COF complexes active in resting macrophages, LPS-stimulated 
macrophages, resting T cells, and TCR-stimulated T cells, we characterized and 
recapitulated known key differences in cell- and stimulus-dependent TF-COF complexes 
(Keenan, 2019). 
 Here we present the hTF array which extends our pilot CoRec array design, that 
was focused on 91 immune-related TFBSs, to a panel of 346 non-redundant consensus 
TFBSs selected algorithmically to represent the known binding repertoire of the human 
TFs. In addition to the standardized and open-source microarray design, we present an 
hTF array analysis framework designed to provide researchers with rapid insight into the 
TF-COF complexes active in different cell states through interactive data analysis and 
visualization modules. We demonstrate the utility of the hTF array and the dedicated 
interactive analysis software by characterizing the diversity of TF-COF complexes active 
in a pilot series of COF recruitment experiments in human macrophages. Furthermore, 
we demonstrate how the interactive analysis modules can be used in conjunction to 
investigate differences in COF recruitment logic at the DNA probe-level, the TF-level, 




represent an attempt to expand our group’s COF recruitment profiling techniques in order 
to enable researchers to investigate the TF-COF complexes active in their system of 
interest (beyond the immune context) as well as enable the development of TF-COF 
biomarkers/signatures. We propose that these TF-COF signatures will provide a valuable 
annotation layer in our efforts to understand context-dependent gene regulation and 
understand the TF-COF complexes mediating aberrant cell states in disease. 
4.3 Results 
4.3.1 The human TF array – scaling CoRec up to a general panel of TFBSs 
 Given the initial success in using the pilot CoRec array design to profile cell type- 
and stimulus-dependent COF recruitment to a panel of 91 immune-related TF sites 
(Keenan, 2019) we sought to expand the approach to a larger panel of TFs relevant 
beyond the immune context. To this end, we have designed the hTF array algorithmically 
in order to cover as many of the TFs as we could while ensuring accurate COF 
recruitment models (see 4.5 Materials and Methods). Briefly, starting with the 452 non-
redundant human TF binding models from the open-source JASPAR 2018 CORE (Khan 
et al., 2018), we further collapsed this set down to 346 non-redundant consensus 
sequences since multiple related TF binding models can be represented by a single 
consensus DNA microarray probe (Fig. 4.1, step 1). For each of these 346 non-redundant 
consensus sequences, on the final microarray design, we included probes corresponding 
to the consensus sequence itself as well as every SNV along the consensus sequence in 
order to allow us to determine COF recruitment motifs (as with CASCADE in Chapter 




of our 346 consensus probes representative of the human TF binding repertoire. This hTF 
probe set can be accommodated in the Agilent 4x180K microarray format, which 
contains 4 replicate copies of each probe set on a single array. Therefore, using this 
microarray design, one can profile COF recruitment in a multiplexed fashion (Fig. 4.1, 
step 2). The example in the schematic shows profiling the recruitment of 2 different 
COFs of interest across 2 cell types in a single set of experiments (Fig. 4.1, step 2). TF-
COF recruitment is profiled in a cell state-specific manner using a nextPBM-based 
approach as with CASCADE in Chapter 3. The hTF array design thereby allows for 
multiplexed COF recruitment investigations across an expansive and diverse panel of 346 
TFs that can be used across any cell type or state of interest. 
 
Figure 4.1: hTF array design overview 
(1) Consensus binding sites from JASPAR CORE set of human TF binding models were 
redundancy reduced. For each consensus site, DNA probes corresponding to the site itself as well 




chamber microarray design allows for multiplexed COF recruitment profiling against the same 
core set of TFBS and SNV probes. 
 
4.3.2 A dedicated interactive software suite to analyze hTF array data 
 As the hTF array was designed to be applied across cell types, conditions, and 
COFs of interest for any research application of interest, we sought to create an 
interactive software suite in order to analyze new results and integrate with previous 
experiments. In order to make analysis of hTF array data more interactive and accessible 
to the researchers who perform the experiments, we developed the hTF array analyzer in 
R Shiny. Through a series of interactive modules such as a dedicated data explorer, 
pairwise scatterplot visualizations, a grid of COF recruitment motifs, and an experiment-
wide recruitment heatmap, the hTF array analyzer software allows researchers to quickly 
explore their results and gain valuable insight into TF-COF recruitment phenomena 
within their cell types or states of interest. 
4.3.3 Exploration of hTF array experimental results using the array analyzer 
 To begin using the hTF array analyzer, experimental data can be uploaded by 
selecting the “Browse…” button within the “Data explorer” tab (Fig. 4.2a, orange arrow). 
Clicking the “Browse…” button opens a file browser where the user is prompted to select 
their formatted hTF array experimental results (Fig. 4.2b). In this example, the user is 
uploading real pilot experimental data obtained using the hTF array design previously 
detailed (Fig. 4.2b). Specific metadata regarding the experimental details and microarray 
design, such as which TF sites are included and which COFs were profiled, are read 




interactive table where the user can explore the full details of their COF recruitment data 
(Fig. 4.2c). Each of the 346 TF probe sets present on the pilot hTF array design contains 
an entry in the table and can be searched for using the “Search” bar at the top right of the 
analyzer window. Optionally, the user may select the “consensus + single variants” tab 
which displays the experimental results for each individual probe in the array design, not 











Figure 4.2: Exploring experimental data with the hTF array analyzer software 
(a) Data can be uploaded to the hTF array analysis analyzer using the “Browse…” button (orange 
arrow). (b) Selecting “Browse…” opens a dialog box that prompts the user to select their z-score 
normalized hTF array results. (c) The interactive “Data explorer” is automatically generated once 
data has been loaded. Users can interact with their experimental results by sorting the columns by 
recruitment strength to the consensus site (orange arrow) or using the search feature to subset the 
full table. Contributions: pilot hTF experiments were performed by RZ with input from DB and 
TS. DB designed the hTF array, the analysis pipeline, and the interactive analyzer software. 
 
 As many of the possible applications of the hTF array platform are discovery-
based in nature, an interactive sorting method is implemented in the “Data explorer” so 
that users may explore which TF sites produced the highest COF recruitment z-scores in 
the experiments performed. For example, sorting the TF entries by the 
“LPS_PMA_P300” column, a label assigned to an experiment used to profile the 
recruitment of coactivator p300 in PMA-differentiated macrophages stimulated with LPS, 
the highest consensus probe z-scores are obtained overwhelmingly by the IRFs (Fig 4.2c, 
orange arrow) which are known LPS-responsive TFs (O’Neill, 2006; Sakaguchi et al., 
2003; Jefferies 2019, Lawrence and Natoli, 2011; Mogensen, 2019). The “Data explorer” 
module allows users to gain immediate insight into interesting TF-COF recruitment 




in the LPS-stimulated cells, in the column labeled “UT_PMA_P300”, an unstimulated 
control cell population, these same consensus sites do not appear to recruit p300 (Fig. 
4.2c). As there are 346 total TF models to consider, the “Data explorer” tab provides an 
initial portal through which users can interact with their data and decide which TFs to 
include in the downstream analysis steps. 
4.3.4 Generation of probe-level pairwise COF recruitment comparisons 
 Common analyses performed in TF-COF recruitment experiments are pairwise 
comparisons of COF recruitment data at the DNA probe level in order to visualize the 
relative recruitment preferences of different COFs to the full array of TFBSs, or the cell 
state-dependent recruitment of a given COF. To facilitate these types of pairwise 
analyses, the hTF array analyzer includes a “Scatterplots” module. Selecting the 
“Scatterplots” panel opens a page where the user is prompted to select two experiments to 
compare as Y and X variables in a dynamically generated scatterplot. For example, to 
explore whether TFs of interest recruit the COF p300 in a condition-specific or 
constitutive manner, a user can select the LPS-stimulated macrophage experiment as the 
Y variable and the experiment from untreated macrophages as the X variable (Fig. 4.3a) 
from the set of experiments included in their uploaded data. The TF selection box is 
implemented with an auto-complete feature to facilitate searching for a TF of interest 
from the full hTF array design (Fig. 4.3a). With each new TF site selected (or deleted), 
the scatterplot is dynamically regenerated to include changes in the z-score axes limits as 























Figure 4.3: Interactive TF-COF recruitment analyses using the hTF array analyzer 
(a) Scatterplots demonstrating a pairwise probe-level comparison between p300 in LPS-
stimulated macrophages (y-axis) versus unstimulated macrophages (x-axis) for a subset of TFs 
listed. The probe colors correspond to the consensus site and all single variant probes for the TFs 
listed. (b) Same as in (a) but at the TF family level. (c) Interactive motif grid displaying the full 
COF recruitment models for p300 recruitment in unstimulated (column 1) macrophages, LPS-
stimulated (column 2), and for NCoR recruitment in unstimulated (column 3) macrophages and 
LPS-stimulated (column 4) for SPI1/PU.1 (top row), RELA/p65 (middle row), and 
RARA::RXRA (bottom row). The JASPAR CORE 2018 reference model for each TF is shown in 
column 5. The search field has an implemented “autocomplete” feature that suggests TF sites 
based on what is currently being typed (highlighted yellow). Contributions: hTF pilot data was 
generated by RZ with input from DB and TS. DB designed the hTF array, analysis pipeline, and 
interactive software. 
 
 By selecting various TF sites interactively within the “Choose TFs to compare” 
box, a researcher can readily identify which TFs (or TF families) likely recruits a given 
COF under the analyzed conditions (Fig 4.3a, p300 recruitment example). To indicate 
general data trends, we display the consensus site and all single nucleotide variant probes 
for a given TF as a single color. In the example shown, the probes representing the IRF 
model (Fig. 4.3a, IRF3 and IRF7) have low p300 recruitment z-scores in the untreated 
condition and high z-scores in the LPS condition, illustrating the strongly LPS-dependent 




highlighted in the “Data explorer” tab (Fig. 4.3c). In contrast, ETS factor probes 
representing the models for ELF1 and ETV2 appear to recruit p300 in a more constitutive 
manner (i.e., these ETS probes have similar z-scores in both resting and stimulated 
conditions) whereas p300 recruitment to SPI1 and SPIB probes occurs more exclusively 
in unstimulated macrophages (Fig. 4.3a). We note that ETS factors have been previously 
demonstrated to interact with the CBP/p300 coactivators (Vo and Goodman, 2001; Yang 
et al., 1998). 
 In more involved analyses with increased numbers of TFs that may obfuscate the 
automatically generated color palette, a user can instead use the “Family-level 
comparison” tab to automatically assign colors to all consensus and single variant probes 
associated with the different TF families included in the pairwise analysis (Fig. 4.3b). As 
an additional layer of abstraction, the analyses can also be performed at the class level by 
selecting the “Class-level comparison” tab (Fig. 4.3b). Overall, the “Scatterplots” module 
within the hTF array analyzer provides users with a quick and user-friendly method to 
generate publication-quality graphs that demonstrate pairwise COF recruitment 
comparisons across TF probe sets of interest. 
4.3.5 Integration of probe-level data to generate TF site COF recruitment models 
 An advantage of using the hTF array platform over other technologies, such as 
genomic COF recruitment profiling techniques like ChIP-seq, is the ability to use SNV 
probes to define COF recruitment motifs that identify the recruiting TFs and quantify the 
impact of nucleotide variants on COF recruitment. The “Motif grid” portal integrates the 




visualize them as sequence logos (Fig. 4.3c). The sequence logos are arranged in a grid 
where rows represent the selected TF probe sets and columns correspond to the different 
COF recruitment experiments of interest in order to allow researchers to visually compare 
recruitment models (Fig. 4.3c). The user can either select to view the models as “Energy 
logos”, which visualize change in recruitment intensity for each nucleotide variant or as a 
more traditional PWM logo that represent TF binding probabilities and enables a more 
direct comparison to the PWM models compiled in large public database such as 
JASPAR (Khan et al., 2018), CIS-BP (Weirauch et al., 2014), UNIPROBE (Newburger 
and Bulyk, 2009; Hume et al., 2015), HOCOMOCO (Kulakovskiy et al., 2013; 
Kulakovskiy et al., 2018), and MotifDb (Shannon and Richards, 2018). In addition to the 
COF recruitment logos obtained experimentally, the “Motif grid” module displays the 
reference JASPAR 2018 CORE binding model for each user-selected TF to enable 
comparisons between empirical COF recruitment models to their corresponding expected 
binding model. 
 The “Motif grid” module allows for sophisticated comparison of COF recruitment 
preferences at different TFBSs of interest. For example, a user might be interested in the 
coactivator p300 or the corepressor NCoR is recruited to diverse TFBSs such as the SPI1, 
RELA, and RARA::RXRA consensus sites in both unstimulated and LPS-stimulated 
macrophages. As shown in the dynamically generated motif grid for this analysis 
example, both the coactivator p300 and the NCoR corepressor complex can be recruited 
to the SPI1 site albeit with distinct nucleotide preferences (Fig. 4.3c, top row). The 




experiments (Fig. 4.3c, columns 3-5) match a different subclass of ETS factor (e.g., 
ELF1, discussed in 4.3.7 below) than the motif in column 1 which more closely 
resembles the SPI1 logo (Fig. 4.3c). These results suggest that different ETS factors may 
be recruiting p300 under different conditions and may be recruiting p300 and NCoR 
under unstimuluated conditions (Fig. 4.3c). In contrast to the SPI1 consensus site, the 
RELA site supports only the recruitment of p300 and in an LPS-dependent manner (Fig. 
4.3c, middle row). This is consistent with NF-κB activation and translocation into the 
nucleus during the pro-inflammatory response. The recruitment model obtained for the 
RELA probes by integrating results over all single nucleotide variant probes associated 
with the RELA consensus is concordant with the expected RELA TF binding model (Fig. 
4.3c, middle row, rightmost column) (Siggers et al., 2012). Finally, though the 
RARA::RXRA complex does not appear to recruit p300 in either condition, it 
demonstrates moderate constitutive recruitment of the NCoR corepressor complex (Fig. 
4.3c, bottom row). The empirical NCoR recruitment models for these sites are concordant 
across cell states (LPS-stimulated and untreated macrophages) and strongly resemble 
canonical nuclear receptor binding models (Fig. 4.3c, bottom row, rightmost column) 
(Penvose et al., 2019). This represents only a few of the numerous comparisons possible 
within a single set of hTF array experiments but provides a valuable example of the 
insight a researcher can gain about the TF-COF complexes and individual preferences 




4.3.6 Generating cell state-level recruitment signatures using the hTF array analyzer 
 An advantage of having a standardized platform that profiles the same set of TF 
consensus sites in each experiment is the possibility of developing cell state-level TF-
COF signatures or biomarkers using the collection of TF-COFs active in a given cell 
state. This would enable researchers to then investigate TF-COF complexes that are 
affected in aberrant cell states (cancer, autoinflammatory, etc.) that may play a role in 
mediating these cell states or whose interactions may be perturbed relative to a matched 
“healthy” cell state. To enable investigations of cell state-specific TF-COF signatures and 
visually summarize the results of a set of hTF array experiments at the complete array-
level, we developed the interactive COF recruitment heatmap as a module of the array 
analyzer software (Fig. 4.4a). The plots display the intensity of a hybrid scoring 
mechanism that scales the COF recruitment strength at a given TF consensus site by the 
Pearson similarity obtained when comparing the empirical COF recruitment model to its 
corresponding expected TF binding model (see 4.5 Materials and Methods). The score 
thereby distinguishes strong consensus models from recruitment sites of similar strength 
that do not produce the expected model at a given TF site. Hovering the cursor over a 
given element within the full heatmap displays this score obtained by a given TF-COF 
complex in a given experiment (Fig. 4.4a, SREBF2 shown). Representing TF-COF 
complexes using this hybrid scoring metric also allows for similarity-based clustering of 
the TF sites (rows) in addition to the collection of experiments performed in a given array 
run (columns) (Fig. 4.4a). Users have the option to deselect experiments (to omit them 




experiment-level similarities, performs the clustering steps again, and plots an updated 
COF recruitment heatmap. 
 
Figure 4.4: Using cell state-level TF-COF recruitment signatures to guide hTF analyses 
(a) Interactive TF-COF recruitment heatmap demonstrating similarity-scaled (see 4.5 Materials 




across the pilot experiments performed. COF recruitment experiments included in this figure are 
shown in the box to the left (all performed using macrophages – see 4.5 Materials and Methods). 
(b) Motif grid comparing the recruitment models obtained at 4 related ETS factor consensus sites 
(rows: SPI1/PU.1, SPIB, SPIC, ELK3). COF recruitment experiments (columns) are as follows: 
P300 (untreated), P300 (LPS-stimulated), BRG1 (LPS-stimulated), TBLR (LPS-stimulated), 
NCoR, NCoR (LPS-stimulated), RBBP5 (LPS-stimulated). The rightmost column displays the 
JASPAR 2018 CORE reference model for each TF. Contributions: DB developed the interactive 
heatmap module with input from RZ, RM, HH, JLK, and TS. Experiments were performed by 
RZ. 
 
 Overall, expressing the results of a given set of hTF array experiments using a 
summary heatmap and clustering TFs and experiments by similarity allows for immediate 
insight that researchers can inspect visually to determine TF-COF recruitment differences 
in their set of experiments. For example, it is apparent in the pilot experiments performed 
that there is a cluster of interferon regulatory factors (IRF8, IRF3, IRF4, IRF9) that 
recruit p300 in a predominantly LPS-inducible manner (Fig. 4.4a) that is stronger in 
intensity relative to other LPS-inducible factors such as RELA, NFKB1, REL, and RELB 
(Fig. 4.4a). The recruitment heatmap thereby represents a powerful method to investigate 
the TF-COF complexes active in a given cell state as well as the state’s similarity or 
dissimilarity to other experiments of interest. In future experiments, this will enable 
researchers to rapidly define the TF-COF complexes active in a cell state and identify 
important differences between “healthy” and “disease” cell states to define TF-COF-level 
biomarkers and signatures. 
4.3.7 Distinct COF recruitment logic mediated by closely related ETS factors 
 Given the scale of the TFBSs profiled on the hTF array (346 total), an important 
function of the “Recruitment heatmap” module is the ability to identify potentially 




further investigate. For example, the TFBSs demonstrating strong COF recruitment in 
experiments of interest can be further investigated using the “Motif grid” module to 
compare and contrast the individual COF recruitment models generated and provide 
insight into the TF-COF complexes active and the nucleotide preferences resulting in 
their recruitment. An interesting test case identified in the pilot hTF array experiments is 
the distinct COF recruitment logic at closely related ETS factor sites that is suggested by 
the recruitment heatmap (Fig. 4.4a). 
 The TF-level (rows) and experiment-level (columns) similarity-based clustering 
in the recruitment heatmap for the pilot series of hTF array experiments shows a clear 
difference between the COF recruitment differences between ETS factors (Fig 4.4a). For 
example, ETV2, ELK3, ELK4, and ELK1 all cluster together based on similarity and 
appear to support the recruitment of several COFs such as p300, TBLR, RBBP5, BRG1, 
and NCoR at moderate levels and consistent with their expected binding models (Wei et 
al., 2010). In comparison, the closely related ETS factors SPIB, SPIC, and SPI1/PU.1 do 
not appear to support the recruitment of TBLR, RBBP5 or BRG1 despite the known 
similarity in their binding preference to the other aforementioned ETS factors (Fig. 4.4a) 
(Wei et al., 2010). Furthermore, SPI1 and SPIC appear to demonstrate distinct NCoR 
recruitment preferences where SPI1 recruits NCoR preferentially in LPS-stimulated 
macrophages and SPIC recruits NCoR preferentially in the unstimulated control 
macrophages. To investigate these phenomena further at the level of these individual 
models, we compared representative ETS factors using the hTF array analyzer “Motif 




ELK3 recruits each of the COFs tested (with the exception of GPS2) at moderate-to-high 
levels with recruitment preferences consistent with its canonical binding model (Fig. 
4.4b, bottom row). Similarly, the COF recruitment experiments for TBLR, BRG1, and 
RBBP5 do not pass the minimal motif plotting threshold (z-score of 1.5) for SPIB and 
SPIC as is shown in the experiment-level recruitment heatmap (Fig. 4.4b, middle rows). 
Though BRG1, TBLR, and RBBP5 are all recruited to the SPI1 consensus site, the 
preferred models for the recruitment of these COFs have a prominent C-rich preference 
5’ relative to the GGAA core ETS element (Fig. 4.4b, top row) which is a feature that is 
inconsistent with the canonical SPI1 binding model (Wei et al., 2010; Mohaghegh et al., 
2019) and explains why the similarity-scaled z-score for these experiments is low (Fig. 
4.4a). In this case, the site is likely being used by another ETS factor with a C-rich 5’ 
preference flanking the core GGAA site, such as the ELK factors, as this preference is 
more consistent with the canonical TF binding models for this ETS sub-family (Fig. 4.4b, 
bottom row) (Wei et al., 2010). Similarly, comparing the NCoR recruitment preferences 
for the closely related SPI1 and SPIC produce a logo more consistent with the SPI1 
binding model in untreated macrophages (Fig. 4.4b, rows 1 and 3, column 5) whereas the 
recruitment logo produced in LPS-stimulated macrophages is more consistent with the 
ELK factors (Fig. 4.4b, rows 1 and 3, column 6) which explains the discrepancies 
observed for SPIC and SPI1 NCoR recruitment observed in the experiment-level 
recruitment heatmap (Fig. 4.4a). Together, these observations demonstrate that the hTF 
array can be used to discern subtle (albeit mechanistically important) differences in COF 




recruitment heatmap with the motif grid feature thereby enables sophistical investigations 
into TF-COF complex recruitment logic even for closely related TFs with similar binding 
preferences. 
4.4 Discussion 
 In this work, we present the hTF array as an extension of our group’s existing 
CoRec approach to survey TF-COF recruitment beyond a small panel of immune-centric 
TFBSs to an expansive panel of non-redundant TFs relevant to any cell type or context in 
humans. This represents a first attempt to expand our TF-COF recruitment profiling 
techniques through a standardized microarray design and an accompanying interactive 
analysis software suite that are both freely available and open-source. The hTF array 
design can be applied in its current iteration to investigate diverse research questions 
related to COF recruitment but can also be improved upon in the future. Though effort 
was made to algorithmically include a diverse and non-redundant panel of TFs, future 
experiments beyond the pilot data presented here will allow for further refinement and 
possibly point to redundant sites than can eliminated from the design and updated in 
future iterations. As the software determines the TFs included in the design at runtime, 
any future iterations, custom alterations, and improvements to the hTF array design will 
be compatible with the existing analysis software. 
 The hTF array analyzer was developed to allow analysis of COF recruitment 
datasets in a more interactive, user-friendly, and accessible to the experimentalists and 
researchers who perform the COF recruitment experiments. The interactive analysis 




at several different scales. To inspect data at the probe-level, scatterplots that visualize 
the COF recruitment intensities at the consensus and SV probes for TFs of interest across 
pairs of experiments can be used. The data explorer and motif grid modules allow users 
to gain additional insight at the TF-level. And finally, the recruitment heatmaps provide 
an array-level summary of TF-COF recruitment across all TFs included in the hTF design 
and all experiments performed. Through examples using pilot hTF array data generated 
from unstimulated and LPS-stimulated macrophages, we demonstrated that these scales 
provide complementary analyses and insight. The data explorer can be used to suggest 
TFs to investigate further using probe-level scatterplots and the motif grid module as 
demonstrated with the example of investigating distinct p300 and NCoR recruitment 
models at diverse TF sites (SPI1, RELA, and RARA::RXR) with different binding and 
recruitment preferences. We further demonstrated utility of the analysis modules by 
inspecting the array-level recruitment heatmap that suggested a distinct recruitment logic 
between closely-related ETS factors. We confirmed the similar but distinct recruitment 
models at the motif-level using the interactive motif grid. We anticipate that these types 
of interactive complementary analyses will empower researchers to gain insight on the 
TF-COF complexes active in their samples and provide actionable hypotheses for further 
analysis and experimentation. 
 In addition to the open-source hTF array design and analysis software, we have 
also introduced the concept of cell state-level TF-COF recruitment signatures which we 
visualized using COF recruitment heatmaps across the panel of TFs. Profiling the 




investigations into differential COF recruitment between cell types/states as well as the 
development of COF recruitment “biomarkers” that can be used to investigate the TF-
COF complexes involved in mediating or maintaining aberrant cell states compared to 
healthy controls. In this pilot study, we have demonstrated that our profiling approach 
captures TF-COF binding events that implicitly account for cell state-specific phenomena 
such as PTMs and differing protein levels in the nucleus. For example, the NF-κB 
complex translocates into the nucleus in macrophages following LPS stimulation (Smale, 
2012; Medzhitov and Horng, 2009) and this presence (or absence in the case of control 
unstimulated macrophages) is reflected in the LPS-specific recruitment of p300 to the 
RELA consensus site (Fig. 4.3c, middle row). Furthermore, LPS-dependent recruitment 
of p300 is detected at IRF3, a TF that requires phosphorylation in order to dimerize in 
vivo (Andrilenas et al., 2018; Tamura et al., 2008; Smale, 2012; Medzhitov and Horng, 
2009), thereby demonstrating that the impact of PTMs are implicitly measured (Fig. 
4.3a). Additional experiments will be required to determine the extent to which changes 
in PTMs or protein levels across cell states are captured in the individual COF 
recruitment motifs (beyond simple presence/absence) and whether the profiling method is 
sensitive enough to detect small changes. Our previous investigations into TF binding 
from nuclear extracts indicate that PTM and protein level changes can be reflected in the 
binding motif obtained (Mohaghegh et al., 2019). Differences were especially evident at 
sites bound by complexes formed by more than one TF where the binding partner is only 
moderately expressed - such as with IRF8 at the cooperative PU.1-IRF8 composite 




protein levels generalizes to COF recruitment motifs across the surveyed TFBSs in the 
hTF array design remains an open question.  
Furthermore, though the TFBSs included in the hTF array design were selected 
from human experiments, the JASPAR2018 CORE database, from which the models 
were selected, contains non-redundant consensus TF models across many vertebrate 
species including mouse. Of the 119 non-redundant mouse-specific models in the 
database, 38 (32%) have a consensus site that is equivalent to one represented by the 
TFBSs already included on the pilot hTF array design (Supplementary Table 4.1). As the 
motif database used to compute PWM similarities of the COF recruitment motifs to 
reference TF binding models is read at runtime, in order to investigate the application of 
hTF to study COF recruitment in other vertebrate models, an expanded database can be 
used without having to alter the hTF array design or analysis software. The applicability 
of the hTF array to study TF-COF binding in other vertebrate cell sources (such as mice) 
will be the topic of future investigations. 
In addition to allowing experimentalists to define TF-COF recruitment signatures 
in cell states of interest, the hTF array platform will provide a means to screen 
compounds to “reverse” these aberrant signatures as many of these enzymatic COFs can 
be targeted using existing compounds (Lasko et al., 2017; Fedorov et al., 2015; Yoon and 
Eom, 2016). These TF-COF signatures/biomarkers will provide an important and 
understudied annotation layer that can be further integrated with other 
technologies/modalities such as RNA-seq and ChIP-seq to enable sophisticated 




studies using the hTF array will investigate this translational potential of the platform as 
well as the concordance with paired COF ChIP-seq data for COFs/conditions of interest 
in order to compare and contrast TF-COF recruitment potential (using hTF array) with 
genome-wide incidence (using ChIP-seq). Overall, we anticipate the standardized hTF 
array design and the accompanying interactive analysis software will be applied to study 
diverse research questions in basic research and translational applications alike. 
4.5 Materials and Methods 
4.5.1 Cell culture 
 THP-1 human monocyte cells (ATCC TIB-202) were cultured in RPMI-1640 
(Thermo #72400120) with 1 mM sodium pyruvate (Thermo #16140071) and 10% heat-
inactivated FBS (Thermo #11360070) in a 37°C incubator with 5% CO2. To prepare 
nuclear lysates, three 50 ml suspension cultures maintained in T-175 flasks were used for 
each stimulation condition. Cells were differentiated at a cell density of 8 x 105 cells/ml 
into adherent macrophages using 25 ng/ml PMA and incubated for 96 hours. After 96 
hours, cells were washed with 1X PBS, fresh growth media was applied, and cells rested 
for 48 hours before stimulation. Differentiated THP-1 cells were stimulated with 1 ug/ml 
LPS for 45 min before harvesting. This section was included and modified from its 
original source with permission from the author (Zhao, 2020). 
4.5.2 Nuclear extract preparation 
 To collect cells after stimulation treatments, THP-1 adherent macrophages were 




in cold PBS supplemented with 0.1 mM protease inhibitor cocktail (Sigma-Aldrich 
#P8340). Cells from three T-175 cultures were collected in 50 ml tubes and pelleted at 
500xg for 5 min at 4°C. Once cell pellets were obtained, to rupture the cell membrane, 
the cell pellet was resuspended in 2 ml of a hypotonic Buffer A (10 mM HEPES (pH 
7.9), 1.5 mM MgCl2, 10 mM KCl, 0.1 mM protease inhibitor cocktail, 0.1 mM 
phosphatase inhibitor cocktail (Sigma-Aldrich #4315), 0.5 mM DTT) and incubated for 
10 min on ice. 20 ul of 10% IGEPAL (Sigma-Aldrich I8896) was added, and the cell 
suspension was vortexed for 10 s. Released nuclei were observed under a 
hemocytometer. Nuclei were pelleted at 500xg for 5 min at 4°C. The nuclear pellet was 
then resuspended in 100 ul hypertonic Buffer C (20 mM HEPES (pH 7.9), 25% glycerol, 
1.5 mM MgCl2, 0.2 mM EDTA, 420 mM NaCl, 0.1 mM protease inhibitor cocktail, 0.1 
mM phosphatase inhibitor cocktail, 0.5 mM DTT). The nuclei suspension was vortexed 
for 30 s, followed by nutation for 1 hour at 4°C on a Hula mixer. The insoluble nuclear 
components were pelleted at 21,000xg for 20 min at 4°C. The supernatant containing 
soluble nuclear proteins was collected, flash-frozen using liquid nitrogen, and stored at -
80°C. Protein concentration of nuclear lysates was quantified by A280 measurement. 
This section was included and modified from its original source with permission from the 
author (Zhao, 2020). 
4.5.3 nextPBM experimental methods 
 PBM experiments were performed on a custom designed single-stranded DNA 
microarray (Agilent Technologies, Design ID 082690, 4 x 180k format). DNA 




described (Berger et al., 2006; Berger and Bulyk, 2009; Mohaghegh et al. 2019). PBM 
wash steps were performed in coplin jars on an orbital shaker at 125 rpm, and all PBM 
steps were performed at room temperature. Briefly, double-stranded DNA microarrays 
were first washed in 0.01% Triton X-100 in HBS (HEPES-buffered saline, pH 7.4) for 5 
min, followed by blocking with 2% NFDM in HBS for 1 hour. Next, arrays were rinsed 
in HBS and incubated with nuclear protein lysate in a binding buffer (0.3% NFDM, 20 
mM HEPES, 100 mM NaCl, 1 mM DTT, 0.2 mg/ml BSA, 0.02% Triton X-100, and 0.4 
mg/ml salmon testes DNA (Sigma D7656)) for 1 hour in the dark. After protein binding, 
arrays were incubated with 20 ug/ml of primary antibody in 2% milk in HBS for 20 min, 
followed by an HBS rinse and 20 ug/ml secondary antibody incubation for 20 min. 
Antibodies used included anti-p300 (Abcam #ab149848), anti-BRG1 (Santa Cruz 
#sc11796), anti-NCoR (Bethyl Laboratories #A301-145A), anti-TBL1XR1 (Santa Cruz 
#sc100908), anti-RBBP5 (Bethyl Laboratories #A300-109A), anti-GPS2 (Abclonal 
#A3901), Alexa488 anti-mouse (Invitrogen #A11131), and Alexa647 anti-rabbit 
(Invitrogen #A21245). Finally, arrays were washed twice in 0.05% Tween-20 for 3 min 
and once in HBS for 3 min before scanning. Arrays were scanned using a GenePix 
4400A scanner, and fluorescence was quantified using GenePix Pro 7.2. Fluorescence 
data was exported and normalized using MicroArray LINEar Regression (Berger et al., 
2006). This section was included and modified from its original source with permission 




4.5.4 hTF array design 
 Non-redundant TF binding models from the JASPAR 2018 core vertebrate set 
were obtained using the JASPAR2018 R bioconductor package. The total 1,564 models 
across model organisms were filtered to those obtained using a human source (human cell 
lines/tissues used for the characterization) resulting in 452 models from different TFs. 
The resulting motifs were then collapsed into consensus sequences using the top-scoring 
base preference at each position and filtered for equivalence based on nucleotide identity 
as well as size of the consensus sequence using a relative size filter of 0.9. Similar size 
was considered along with equivalent consensus sequences in order to avoid the scenario 
where a half-site within a composite site would be eliminated from the final design. 
Filtering by similar size and nucleotide identity resulted in 346 TF models to be included 
in the final design. To account for possible additional nucleotide determinants beyond the 
positions covered by the TF consensus binding sites, a random non-repeating 2 base pad 
was added to both ends of each consensus sequence. For each of these 346 modified 
consensus sequences, DNA probes corresponding to each possible SNV across these 
sequences were also generated. To account for size differences between probes, a 34-base 
backbone sequence was generated algorithmically such that the nucleotide at each 
position was generated randomly with the constraint that sequential positions contain 
non-repeating nucleotides. Each consensus and SNV sequence generated was then 
inserted into the backbone sequence beginning at the 5’ end such that the site being 
profiled is located at the end furthest away from the glass slide that the probe is fixed to. 
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These full 34-base targets were then embedded within a larger probe (total: 60 bases) as 
follows: 
GC cap + 34 base target region (TF site or SNV within backbone) + 24 base primer 
261 background target DNA probes were also included in the design in order to 
be able to estimate background fluorescence intensities in the experiments. These regions 
were selected as 34-base genomic segments from the human genome (hg38). The final 
design as well as the script used to design the array are open source and have been made 
freely available on Github (https://github.com/Siggers-Lab/hTF_array). 
4.5.5 hTF array analyzer interactive software 
The hTF array analyzer software is written using the shiny interactive web 
programming framework in R (RStudio Inc., 2013) with the visual theme “flatly” from 
the shinythemes R package (Chang, 2018). As with the final microarray design and the 
script used to generate the design, the hTF array analyzer is open source and has been 
made available on Github (https://github.com/Siggers-Lab/hTF_array). Normalized 
fluorescence datasets obtained from hTF array experiments are first log-transformed and 
z-scores are computed against the distribution of 261 background probes as previously 
described (Mohaghegh et al., 2019; Penvose et al., 2019; Keenan et al., 2020; Bray et al., 
2020). The “Data explorer” module uses the javaScript DT package (Xie et al., 2020) to 
display interactive data tables of the COF fluorescence z-scores obtained at each of the 
346 TF consensus sites. The “Scatterplot” module compares user-selected COF 
recruitment experiments at user-selected TF sites to compare z-scores obtained across 
experiments in a pairwise manner. The scatterplots are plotted using the ggplot2 package 
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(Wickham, 2016) with automatically generated colors for probes belonging to each TF 
group. The “family-level” and “class-level” tab regroups the user-selected probe groups 
based on their family or class annotation respectively and recolors the probe sets 
accordingly. The “Motif grid” module displays COF recruitment logos obtained at user-
selected TFs and user-selected experiments plotted using the ggseqlogo R package 
(Wagih, 2017) and arranged as grids using the gridExtra package (Auguie, 2017). The 
COF recruitment “energy” logos summarize the z-scores obtained at a given TF 
consensus binding site (within a given experiment) as well as all of the probes 
corresponding to single nucleotide variants along the profiling region as previously 
described (Andrilenas et al., 2018; Mohaghegh et al., 2019; Penvose et al., 2019). In the 
“Recruitment heatmap” module, the “energy” motifs obtained at each TF (and in each 
experiment) within an array are first transformed into probability-based position-weight 
matrices using the Boltzmann energy distribution as previously described (Andrilenas et 
al., 2018; Mohaghegh et al., 2019; Penvose et al., 2019). To obtain the hybrid scores 
displayed in the “Recruitment heatmap” module, the motif database used in the initial 
generation of the array design (a filtered version of the JASPAR 2018 CORE) is first 
loaded using the universalmotif package (Tremblay, 2019). The z-score obtained 
experimentally for COF recruitment at each TF consensus site (and each experiment) is 
then scaled using the corresponding similarity of the COF recruitment PWM to its 
expected TF binding model (computed as a length-normalized Pearson correlation 
coefficient across binding site positions) to generate each hybrid score using the 
TFBSTools R package (Tan et al., 2016). The heatmaply package is used to generate the 
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interactive heatmap plots (Galili et al., 2017). Default distance metric (Euclidean) 




4.6 Supplementary Information 
ID TF name Consensus 
sequence 
Species Equivalent hTF 
model 











Mus musculus   
MA0063.1 Nkx2-5 TTAATTG Mus musculus BSX,ESX1,RAX 
MA0067.1 Pax2 AGTCACGC Mus musculus   
MA0078.1 Sox17 CTCATTGT
C 
Mus musculus   





Mus musculus   
MA0111.1 Spz1 AGGGTAA
CAGC 
Mus musculus   
MA0125.1 Nobox TAATTGGT Mus musculus ESX1,GBX2 
MA0135.1 Lhx3 AAATTAAT
TAATC 





Mus musculus   
MA0062.2 Gabpa CCGGAAGT
GGC 






Mus musculus   
MA0047.2 Foxa2 TGTTTACT
TAGG 




Mus musculus   
MA0151.1 Arid3a ATTAAA Mus musculus ALX3,DUX4,DUX
A,GSX1,GSX2,MN
X1,PHOX2A 


























Mus musculus   
MA0463.1 Bcl6 TTTCCTAG
AAAGCA 






Mus musculus   
MA0480.1 Foxo1 TCCTGTTT
ACA 
Mus musculus   
MA0482.1 Gata4 TCTTATCT
CCC 
Mus musculus   
MA0483.1 Gfi1b AAATCACA
GCA 
Mus musculus   
MA0485.1 Hoxc9 GGCCATAA
ATCAC 
Mus musculus   
MA0493.1 Klf1 GGCCACAC
CCA 






Mus musculus   
MA0499.1 Myod1 TGCAGCTG
TCCCT 
Mus musculus   
MA0500.1 Myog GACAGCTG
CAG 





Mus musculus   
MA0505.1 Nr5a2 AAGTTCAA
GGTCAGC 
Mus musculus   
MA0509.1 Rfx1 GTTGCCAT
GGCAAC 
Mus musculus RFX2 
MA0514.1 Sox3 CCTTTGTT
TT 
Mus musculus   
MA0515.1 Sox6 CCATTGTT
TT 
Mus musculus   
MA0518.1 Stat4 TTTCCAGG
AAATGG 





Mus musculus   
MA0520.1 Stat6 CATTTCCT
GAGAAAT 
Mus musculus   
MA0521.1 Tcf12 AACAGCTG
CAG 
Mus musculus   
MA0035.3 Gata1 TTCTTATC
TGT 






Mus musculus   





Mus musculus   
MA0594.1 Hoxa9 GCCATAAA
TCA 
Mus musculus   
MA0601.1 Arid3b ATATTAAT
TAA 
Mus musculus   
MA0602.1 Arid5a CTAATATT
GCTAAA 
Mus musculus   
MA0603.1 Arntl GGTCACGT
GC 
Mus musculus   
MA0604.1 Atf1 ATGACGTA Mus musculus FOSL1::JUND(var.2
) 





MA0607.1 Bhlha15 CCATATGT Mus musculus BHLHE22 
MA0608.1 Creb3l2 GCCACGTG
T 
Mus musculus   
MA0609.1 Crem TATGACGT
AA 
Mus musculus   












Mus musculus   
MA1099.1 Hes1 GGCACGC
GTC 
Mus musculus   
MA0616.1 Hes2 TAACGACA
CGTGC 
Mus musculus   
MA0617.1 Id2 GCACGTGA Mus musculus   
MA0622.1 Mlxip GCACGTGT Mus musculus HEY1 
MA0623.1 Neurog1 ACCATATG
GT 
Mus musculus OLIG2 
MA0626.1 Npas2 GGCACGTG
TC 
Mus musculus HEY1 
MA0627.1 Pou2f3 TTGTATGC
AAATTAGA 








Mus musculus   
MA0632.1 Tcfl5 GGCACGTG
CC 
Mus musculus HES5,HES7 
MA0633.1 Twist2 ACCATATG
TT 




Mus musculus   
MA0643.1 Esrrg TCAAGGTC
AT 
Mus musculus ESRRB 
MA0676.1 Nr2e1 AAAAGTC
AA 
Mus musculus   
MA0677.1 Nr2f6 GAGGTCA
AAGGTCA 
Mus musculus   
MA0681.1 Phox2b TAATTTAA
TTA 
Mus musculus PHOX2A 




MA0075.2 Prrx2 CCAATTAA Mus musculus BSX,ESX1,RAX 
MA0512.2 Rxra GGGGTCA
AAGGTCA 
Mus musculus RXRB 
MA0704.1 Lhx4 TTAATTAA Mus musculus LMX1A,POU6F1 
MA0705.1 Lhx8 CTAATTAG Mus musculus EMX2,EN1,GBX1 
MA0709.1 Msx3 CCAATTAA Mus musculus BSX,ESX1,RAX 
MA0124.2 Nkx3-1 ACCACTTA
A 
Mus musculus NKX3-2 















Mus musculus RARA 
MA0739.1 Hic1 ATGCCAAC
C 
Mus musculus   
MA0742.1 Klf12 GACCACGC
CCTTATT 







Mus musculus   
MA0461.2 Atoh1 AACATATG
TT 





Mus musculus BHLHE40 
MA0832.1 Tcf21 GCAACAG
CTGTTGT 
Mus musculus   
MA0840.1 Creb5 AATGACGT
CACC 


































Mus musculus   
MA0869.1 Sox11 AACAATTT
CAGTGTT 
Mus musculus   
MA0870.1 Sox1 AACAATA
ACATTGTT 




Mus musculus   
MA0877.1 Barhl1 GCTAATTG
CT 
Mus musculus   
MA0879.1 Dlx1 CCTAATTA
TC 
Mus musculus   
MA0880.1 Dlx3 CCAATTAC Mus musculus DLX6 







Mus musculus   












Mus musculus   
MA0904.1 Hoxb5 ACGGTAAT
TAGCTCAT 




Mus musculus   
MA0911.1 Hoxa11 GGTCGTAA
AATT 
Mus musculus   
MA0912.1 Hoxd3 TTGAGTTA
ATTAACCT 
Mus musculus   
MA0913.1 Hoxd9 GCAATAA
AAA 
Mus musculus   
MA1153.1 Smad4 TGTCTAGA Mus musculus SMAD3 
 
Supplementary Table 4.1: Mouse-specific TF models from JASPAR2018 included in hTF 
array design 
The table lists mouse-specific TF model accessions from the JASPAR2018 database (119 total) 
and indicates equivalent hTF array models (if applicable). TF-COF binding for mouse TF models 





CHAPTER FIVE: Discussion and future work 
5.1 New methodologies for analyzing TF and TF-COF binding 
 Motivated by the widening gap between the identification of disease-associated 
non-coding variants and our ability to mechanistically characterize them (Gallagher and 
Chen-Plotkin, 2018), the collection of work presented here represents a novel toolkit for 
researchers to begin to study the link between DNA variants and the aberrant recruitment 
of COFs. In Chapter 2, I presented the nextPBM as an improvement over the traditional 
PBM protocol using integrative genomics approaches to select the sequences profiled in 
the pilot microarray design. In addition to the improvements observed using nuclear 
extract in place of IVT proteins for profiling experiments, we investigated NE 
modifications such as enzymatic treatment using a phosphatase as well as immune-
depletion of a cooperative factor providing researchers with a versatile toolkit to study 
protein-DNA complexes of interest through manipulation of the wild-type NE. In 
addition, the integrative genomics techniques used to select the sites included in the pilot 
nextPBM array to characterize the cooperative binding between PU.1 and IRF8 in 
monocytes provides researchers with a general framework through which they can screen 
suspected cooperative elements of interest and characterize the nucleotide determinants 
of TF-TF cooperativity to those sites. We expect that users will continue to expand the 
nextPBM toolkit in new and interesting ways in order to tackle their research questions as 
we have done in our own group with the CASCADE and hTF array approaches. 
 As an extension of the nextPBM platform, in Chapter 3, I presented CASCADE 




dependent manner. In our investigations using the technique to characterize COF 
recruitment to CREs and ncSNPs, we demonstrated that COF recruitment to these 
elements can be characterized at nucleotide resolution directly from cell NEs. Using an 
SV probe technique, we simultaneously uncovered the nucleotide determinants of COF 
recruitment to these locations as well as the regulators underlying their recruitment, thus 
providing researchers with a blueprint for future mechanistic characterizations of CREs 
and non-coding polymorphisms using this site-specific COF recruitment motif approach. 
In addition, using a combined nextPBM-based differential COF recruitment screen and 
subsequent CASCADE-based follow-up we also developed an HT approach to 
mechanistically annotate ncSNPs and link these polymorphisms to the complexes that 
mediate the effector functions of gene regulation. This combined 2-step screening and 
follow-up approach has the potential to be widely adopted for research involving DNA 
variants in the non-coding genome. Overall, based on our own demonstrations in Chapter 
3, we envision CASCADE, and other nucleotide resolution techniques like it, will be 
instrumental in efforts to mechanistically annotate the effects of NCVs to provide more 
rapid and facilitated functional characterizations of the backlog of disease-associated 
variants uncovered by GWAS. 
 With the design of the human TF array in Chapter 4, we hoped to further 
standardize our COF recruitment approaches so that a breadth of research questions 
related to TF-COF complexes and DNA variants could be addressed using a single 
expansive array design. Toward this goal of expanding our approach, we designed the 




software used to algorithmically generate it. In addition, we designed an analysis 
software to allow users to interact with the results of their hTF array experiments. We 
also present the concept of a COF recruitment “signature” and provide users with the 
means to build these signatures within our software. Ultimately, we hope that other 
researchers will begin to explore their systems using our standardized COF recruitment 
platform and we expect the concept of a COF recruitment signature to be important in 
future investigations to define TF-COF interactions within normal cell states and aberrant 
cell states alike. 
 With our future plans to further integrate our COF recruitment profiling 
approaches with existing orthogonal techniques and our planned improvements to the 
platforms presented in this work (discussed at length later in this chapter), we hope to 
further demonstrate the utility and versatility of these COF-centered approaches and 
provide the research community with a toolkit to facilitate investigation into the role of 
TF-COF complexes and NCVs in gene regulation and disease. 
5.2 TF-COF complexes – moving beyond TF binding 
 High-throughput methods for studying TF-DNA binding (e.g., MITOMI, SMiLE-
seq, CSI, PBM, SELEX-seq, etc.) (Berger et al., 2006; Berger and Bulyk, 2009; Maerkl 
and Quake, 2007; Isakova et al., 2017; Puckett et al., 2007; Warren, 2005; Jolma et al., 
2010; Slattery et al., 2011) have had a tremendous impact on our understanding of TF 
function and genome-scale analysis of gene regulation, leading to large databases of 
widely-used TF binding models (Fornes et al., 2020; Weirauch et al., 2014; Wingender, 




al., 2018) have been used to study TF-DNA binding in a more native cellular context by 
using TFs directly from cell nuclear extracts instead of using purified TF samples. 
However, COF recruitment and the assembly of TF-COF complexes in a cell type- and 
state-specific manner have not been examined using these approaches. Together, this 
demonstrates a historical focus on TF binding where the nucleotide determinants of COF 
recruitment and the assembly of TF-COF complexes in the cellular context has remained 
largely unexplored due in part to technological limitations.  
 In this work, we have demonstrated with CASCADE (in Chapter 3) and the hTF 
array (in Chapter 4) that COF recruitment, and by extension the assembly of TF-COF 
complexes, can be directly profiled in an HT manner using cell NEs representing an 
important technological and conceptual advance. Analogous to TF binding motifs, we 
have also introduced the concept of a COF recruitment motif that represents the DNA 
sequence-specificity of COF recruitment. The concept of a recruitment motif can be used 
to describe COF recruitment to TF sites in a local region (as with the TFBSs included on 
the hTF array or the genomic NCVs investigated with CASCADE) as well as larger 
CREs (for example, the CXCL10 promoter segment characterized with CASCADE). We 
have demonstrated as well that COF motifs can be used to infer the identity of the TF (or 
TF family) recruiting a COF to a particular DNA sequence. We note that this approach is 
different from COF ChIP-seq, which identifies the genomic loci to which a COF is 
recruited but does not identify the TFs involved at individual loci nor the DNA-sequence 
dependence of COF recruitment at single-nucleotide resolution. Given that COFs can be 




the ability to profile numerous TF-COF complexes in parallel – an approach we 
expanded to 346 TFBSs with the hTF array. 
 The COF recruitment profiling techniques developed for this work, such as 
CASCADE and the hTF array, thereby offer conceptually new high-throughput 
approaches to study gene regulatory complexes that move beyond traditional TF binding 
investigations. We anticipate that the ability to assay COF recruitment afforded by 
CASCADE and the hTF array will provide a deeper general understanding of how DNA 
sequence and regulatory complexes control gene expression and will enable researchers 
to investigate new types of questions about the relationship between DNA variants, 
regulatory complexes, chromatin/histone modification, and gene expression. 
5.3 Mapping regulatory inputs to CREs 
 One of the major applications of CASCADE, detailed extensively in Chapter 3 of 
this work, is profiling COF recruitment to large CREs to comprehensively examine the 
nucleotide determinants of these recruitment events in a cell type- and stimulus-
dependent manner. To create more comprehensive models of the role of TF-COF 
complexes in gene expression, CASCADE will be integrated with modalities such as 
mass spec and MPRA (discussed below). In addition, to increase the throughput of 
CASCADE to profile more CREs, we discuss the CASCADE XL concept as a 2-step 
alternative to the CASCADE CRE characterization technique presented in Chapter 3. 
 The requirement for COF antibodies may preclude the use of CASCADE in more 
discovery-based applications where prior knowledge of the COFs mediating gene-




techniques with an antibody-free proteomics approach, mass spec will be used to identify 
the key components of the complexes assembling at CREs of interest. Integration of 
CASCADE with mass spec will allow us to determine the extent to which full gene 
regulatory complexes are assembled on our arrays and provide the additional benefit of 
suggesting COFs that may be of interest to profile. Comparison of CASCADE with mass 
spec will thereby allow us to build more complete models of gene regulatory complex 
binding to CREs. 
 An open question in gene regulation is how transcriptional output is mediated by 
both TF affinity-dependent and independent mechanisms (Grossman et al., 2017; 
Andrilenas et al., 2018; Penvose et al., 2019; Kribelbauer et al., 2019; Louphrasitthiphol 
et al., 2020). To investigate the concordance (and discordance) between CASCADE-
based COF recruitment results and changes in gene expression, CASCADE will be 
compared with MPRA reporter output. Since the input sequence library for MPRAs can 
be customized, probe sets including all single variants within a CRE can be screened for 
COF recruitment (using CASCADE) and gene expression changes (using MPRA) in 
matched cell types and stimulation conditions. Furthermore, cell state-specific integration 
of COF recruitment with reporter activity will further clarify an emerging role for PTMs 
in regulating TF activity given that a recent study has demonstrated that state-specific 
p300-mediated acetylation of a TF can both reduce its DNA-binding affinity while 
increasing transcriptional output (Louphrasitthiphol et al., 2020). These investigations 
relating COF recruitment with reporter activity will provide detailed gene regulatory 




and gene expression changes. These gene regulatory models will also help clarify 
whether COF recruitment is mediated by single sites within a CRE or cooperatively 
distributed across several closely interspersed TF sites (Giorgetti et al., 2010; Kribelbauer 
et al., 2019; Louphrasitthiphol et al., 2020). We anticipate that integrating our 
CASCADE results with MPRA results will further position CASCADE as a useful assay 
to map the functional inputs of CREs. 
 A limitation of the CASCADE approach to characterize CREs is the number of 
DNA probes needed to employ the combined CRE tiling and SV probe approach to 
generate full CRE-wide recruitment motifs. To address this limitation, we have designed 
an alternate approach to screen a CRE (or group of CREs) of interest for COF 
recruitment prior to employing the full CASCADE approach. This concept, called 
CASCADE XL (Fig. 5.1), effectively leverages the success of the 2-step screening 
approach previously used in Chapter 3 to screen ncSNPs for differential COF 
recruitment. As with the differential COF ncSNP screen, a panel of COFs can be used to 
determine which overlapping tile probes within a CRE support the recruitment of these 
COFs. Only the tiles exhibiting significant COF recruitment are then included in a 
follow-up array where the full CASCADE SV probe approach is used to uncover the 
nucleotide determinants of COF recruitment and enable an inference as to the specific TF 






Figure 5.1: CASCADE XL concept for screening and characterizing CREs with increased 
throughput 
(1) CRE CASCADE tiling procedure as used previously in Chapter 3 of this work. SV probes for 
each position on each tile were included in a CASCADE array design to generate continuous 
CRE-wide COF recruitment motifs. (2) CASCADE XL concept pre-screens the same tile probes 
for COF recruitment prior to the full CASCADE procedure enabling an increased screening 
throughput with the caveat that gapped CRE COF recruitment motifs are generated for significant 
sites only. Contributions: CASCADE XL concept was developed by DB with input from TS and 
HH. 
 
 Use of the CASCADE XL approach in place of the full CRE CASCADE 
technique outlined in Chapter 3 would result in an increased CRE screening throughput at 
the expense of profiling resolution. In place of a continuous CRE-wide COF recruitment 
motif (Fig. 5.1, part 1), the 2-step CASCADE XL approach would produce “gapped” 
CRE recruitment motifs that specifically examine local regions within the CRE that 
support the recruitment of one or more COFs screened (Fig. 5.1, part 2). Though we have 




a useful means to investigate groups of related CREs, such as the collection of all 
cytokine/chemokine promoters, in a single array design to compare and contrast the use 
of these CREs in different cell types and conditions. 
5.4 Screening NCVs for COF recruitment 
 As one of the major innovations presented in this work was the development of an 
HT differential COF recruitment screen, we have already performed a series of 
experiments design to test possible improvements in the detection of significant 
differential COF recruitment events. Within the probes used in the differential COF 
recruitment screen in Chapter 3, the variant position being profiled was located at the 
center of the profiling target region (Fig. 5.2a). Placement of the variant position within 
the center of the target region ultimately may result in suboptimal detection of COF 
recruitment at TFBS positions that are not centered. To address this possible bias, we 
designed an improved screen and tested it for the detection of differential COF 
recruitment at promoter variants associated with the development of cancer. 
 To circumvent the possible biases associated with having the variant position 
occur in the middle of the profiling region (Fig. 5.2a), we now include 3 pairs of probes 
representing the same variant but in different registers - with the variant position 
centered, shifted 5 bases to the left, and 5 bases to the right  (Fig. 5.2b-c). In a pilot test 
where we compared the results of a triple register differential COF recruitment screen 
against the reference single register design for a set of NCVs associated with cancer 
development and control NCVs. In the triple register screening design, we observe 




(Fig. 5.2d). The improvements to our NCV screening method outlined here should result 
in a more robust differential COF recruitment detection screen that is better suited for 
more discovery-based research projects. 
 
Figure 5.2: Improved COF recruitment screen overview and application to study cancer 
promoter variants 
(a) Previous differential COF recruitment screen design used thus far. The reference and variant 
alleles being assayed appear exclusively at the center of the DNA probe target region. (b) An 
improved screen design uses 3 different “registers” to assay the variant position toward the 5’ 
end, in the middle, and at the 3’ end of the probe target region. (c) Assaying TF-COF complex 
formation at 3 different registers allows for more robust detection of statistically significant 
differences. (d) Statistically significant differential COF recruitment detected using the improved 
triple register design (y-axis) versus the previous single register design (x-axis) for SMARCA4 
(left), TBL1XR1 (middle), and HDAC1 (right). Sites assayed represent promoter mutations 
associated with cancer development and altered TF binding (red) and control mutations not not 
associated with cancer development or predicted to alter TF binding (blue) profiled using HT29 
cell nuclear extracts. Contributions: The improved triple register screen was designed by David 
Bray with input from Trevor Siggers and Heather Hook (HH). Sites profiled were selected by 
Sebastian Carrasco Pro and Juan Fuxman Bass as part of an ongoing collaboration. HH 
performed the experimental work. 
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Consistent with our efforts to improve our differential COF recruitment screens, 
an exciting future avenue will be to use our NCV screening approach to investigate 
compounds for potential therapeutic intervention. Many COFs mediate gene-regulatory 
functions enzymatically and commercially available compounds exist to inhibit these 
enzymatic functions (Yoon and Eom, 2016; Lasko et al., 2017; Fedorov et al., 2015). We 
explored the idea of using our platform to screen therapeutics briefly in Chapter 2 with 
the initial introduction of the nextPBM platform where we used a general phosphatase to 
disrupt the post-translational modifications required for cooperative interaction between 
PU.1 and IRF8. We can extend this concept in the future to our NCV differential COF 
recruitment screens to determine whether we can use compounds to target aberrant COF 
recruitment events gained with NCVs. 
5.5 Expanding our repertoire of COF antibodies 
A focus of our research moving forward will be the screening and validation of an 
increased number of COF antibodies for use in our array-based assay. The hTF array 
approach detailed in Chapter 4 represents the ideal platform to use in such investigations. 
By its nature, the hTF array can be used to rapidly screen the use of COF antibodies and 
since the set of TFs profiled is the same across experiments, the results across different 
antibodies for the same COF can in principle be compared in order to determine which 
would be best to use for research purposes. The hTF platform will thereby enable both 
rapid expansion in our repertoire of COF antibodies as well as optimization of the choice 




 Though we envision that our repertoire of COF antibodies will undoubtedly 
increase as we scale up our investigations using the hTF array platform, we are currently 
inherently limited to COFs with available antibodies. As an alternative to using 
antibodies against the native COF complexes or subunits, we have begun investigations 
into using GST-tagged cloned COF subdomains in place of the native COF complexes. 
Not only will this allow us to expand our antibody repertoire, but this approach will also 
enable investigations into domain-specific recruitment of COFs to TF sites. Mapping the 
recruitment of subdomains within a given COF and comparing these results to those 
obtained with the native COF should provide a more nuanced view of the logic of TF-
COF interactions. Early preliminary experiments into mapping the TFs that recruit 
individual subdomains of the p300 histone acetyltransferase in LPS-stimulated 
macrophages have been promising. Using GST-tagged subdomain clones of the p300 
coactivator (Fig. 5.3a), we recapitulated known domain-TF interactions (Fig. 5.3b). 
Larger scale experiments are needed in order to determine whether these exogenously 
introduced components will accurately recapitulate the recruitment logic of the native 






Figure 5.3: COF subdomain-specific recruitment profiling using GST-tagged clones 
(a) Subdomains of a larger coactivator can be cloned and GST-tagged to enable subdomain-
specific recruitment experiments. (b) Pilot recruitment data comparing the native p300 
recruitment to CH1, KIX, and CH3 subdomains for NF-κB (top row) and ETS (bottom row) from 
the original CoRec array design. Contributions: Subdomain-specific CoRec pilot experiments 
were performed by Rose Zhao with input from Trevor Siggers and Jessica Keenan. David Bray 
designed and performed the automated CoRec analysis. 
 
 These additional investigations into expanding our COF repertoire will also 
enable interesting new profiling strategies. For example, pooling several of the GST-
tagged subdomain components into a single experiment would allow for the examination 
of several COF complexes implicitly using a single anti-GST antibody. For example, 
pooling tagged subunits designed from various HATs such as p300, CBP, and their 
associated cofactors such as PCAF, and profiling their collective recruitment using the 
anti-GST antibody could enable to the construction of an “activation” signature that 
reveals the TFs responsible for mediating activator COF recruitment in a given cell type 
or context. Similarly, activator, repressor, and chromatin remodeling subunits could all be 
pooled into a single microarray chamber to build a signature of TFs broadly responsible 
for coordinating the major gene-regulatory effector functions in a cell type/context. As 
we expand our COF repertoire, we envision that these “meta”-signature approaches will 
become invaluable in determining which TFs most contribute to gene-regulatory function 
in a given condition. These signatures will provide a valuable annotation layer to be 
integrated with other modalities such as gene expression profiling and chromatin 
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